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The term “Amyloid” describes the precursor proteins misfolded and aggregated into fibril-like 
structures that are built by cross β-sheet subunit. The disease caused by depositing amyloid fibril 
in tissues and organs is called amyloidosis. Amyloidosis can not only damage tissues and organs 
but also could lead to death. More than thirty amyloidoses have been observed in human body, 
these amyloidoses can be classified to mainly two types, local and systemic amyloidoses. One 
well-known local amyloidosis, amyloid β amyloidosis (Aβ amyloidosis) is caused by its precursor 
protein amyloid β (Aβ) misfolding and aggregation, and Aβ amyloidosis leads to Alzheimer’s 
Disease (AD). Patients who developed AD suffer from the neurodegenerative disorder and losing 
memory. On the other hand, precursor protein serum amyloid A (SAA) can cause so-called 
systemic amyloidosis, specifically amyloid A amyloidosis (AA amyloidosis). AA amyloidosis can 
cause damage in tissues and organs non-localized in the human body, such as heart, spleen, kidney, 
and liver. The mechanisms for amyloid fibril formation and the difference in toxicity among 
species for both Aβ and SAA remain unclear, especially missing is the atomic detail of structural 
and dynamic information. In this thesis, molecular dynamics (MD) and other enhanced sampling 
methods are applied to probe the structural dynamics for Aβ and SAA systems. Specifically, the 
study in chapter 3 for Aβ derives 1) the critical size, 2) the important role of last two hydrophobic 
residues on C-terminus to stabilize structures and 3) potential packing patterns to form two-fold 
structures, for the newly found S-shaped Aβ fibril structure. As for SAA, our study of the N-
terminal fragments revealed that the key salt-bridge interaction between residues 1R and 9E 





bridge can initialize the amyloid formation process, see details in chapter 4. Furthermore, our 
simulations of hexamer and monomer fragments and full-sized SAA protein suggested that SAA 
amyloid formation happens after the failure of a downregulation mechanism. The downregulation 
mechanism is proposed based on the following two observations. First, the difference in stability 
between full-sized hexamer and the hexamer built from shorter fragments, second, different 
structural properties between variant monomer motifs, third, different pH conditions, details can 
be seen in chapter 5. Recently, a high resolution SAA fibril structure has been resolved via Cryo-
EM. In order to understand of SAA fibril formation better, we study the thermodynamic stability 
of the fibril via molecular dynamics simulations. Our preliminary results in chapter 6 reveal that 
SAA fibril formation starts from monomers stacking into meta-stable one-fold subunit and then 
packing into stable fibril with two-fold symmetry. The two-fold two-layers system is the minimum 
size to maintain the fibril stable. The meta-stable structure can be stabilized under acidic conditions, 
it is consisted with our previous observation that low pH is critical to initialize SAA mis-folding 
and aggregation. We also discussed the roles of N-terminal amyloidogenic region and C-terminal 
disordered region play in SAA fibril formation. The data and results generated from our studies 
(chapters 3 - 6) reveal the posterities of amyloids and provide physical explanations at the atomic 
level, also this information of precursor protein downregulation, amyloid formation, and toxicity 
















Chapter 1. Scope and Contribution of the Thesis 
 
 
1.1. A Short Overview 
 
Amyloidosis is a  disease caused by the buildup and depositionof abnormal amyloid fibrils in 
human tissues which can further cause tissue damage, dysfunction of organs, and eventually 
death.1 Amyloid fibrils formation follows a sigmoidal growth kinetic pattern, a pattern that is 
typically observed for nucleated self-assembly reactions. Figure 1.1 represents the stages of 
amyloid formation. Three significant phases are observed: the lag phase, the growth/transition 
phase, and the saturation/steady phase.2, 3 The lag phase is the period during which the amyloid 
becomes nucleated, the saturation phase represents the concentration required to reached 
equilibrium, the transition/growth phase describes the highest conversion rate from monomers or 
oligomers to the fibril state. Understanding the dynamics of each stage and the transition between 
different phases can primarily benefit human health by offering guidance in developing a new drug 
or treatment against amyloidosis. Our work in this thesis provides the protein structural dynamic 
data which reveals the molecular underpinning of different phases (steady phase of Aβ，lag phase 
and steady phase of SAA) in the amyloid formation process by taking advantage of molecular 
dynamics (MD) and other advanced computational approaches. Specifically, chapter 2 provides 
backgrounds of protein folding and related simulation methods. Work in chapter 3 reveals the 
critical size and potential packing of recently found amyloid β (Aβ) fibril structure. Work in 
chapter 4-6 answers what role does N-terminal region, cleavage or acidic condition play in down-





In summary, the scope of this thesis covered our work in studying the post / steady phase of 
amyloid fibril formation of Aβ and the lag and steady phase for SAA. Many previous studies 
focused on the elongation/transition phase for Aβ, however the elongation phase for SAA was 
rarely reported. Studying the transition between native structure and fibril is critical to understand 
the mechanism of SAA fibril formation and provide the potential guidance for drug design and 





Figure 1.1. Aggregation states over time 4 (Iannuzzi, C.;  Irace, G.; Sirangelo, I., Molecules 2015, 
20 (2), 2510-2528. Open access journal and no copyright is required)  
 
1.2. Stability Study of Recently Found Amyloid β (Aβ) motif 
 
 
Amyloidosis starts with the precursor protein misfolding and aggregating. For example, Amyloid 
β (Aβ) is the precursor protein that triggers Aβ amyloidosis and leads to Alzheimer’s Disease 
(AD).5-7  The deposition of Aβ fibril in the human brain can cause senile dementia which is a result 





reported as fibril structures that are assembled from peptides of lengths from 37 to 42 residues. 
Two most common fragments are Aβ1-40 and Aβ1-42, and the latter one reported to have greater 
toxicity. Also, compared to the Aβ mature fibril, the soluble oligomers are more toxic to cell.7-9 
The in vitro observations of oligomers assembled by peptides with the same sequence are not 
necessarily to end up with the same structure; the polymorphic property of Aβ oligomers and fibrils 
could lead to different pathologies.10, 11 Several oligomer structures have been reported before. 
There are two significant types of fibrils known today, U-shaped and S-shaped fibril structures. 
More than five variations of U-shaped Aβ1-40 structures have been reported. The Aβ1-42 U-shaped 
structure contains two β-strand. They cross regions of residues 18-26 and 31-42 and a loop region 
connects two β-strand (see figure 1.2a). 11-13  
 
Until recently only a U-shaped low-resolution structure, discovered in 2005, was available for Aβ1-
42. In 2015 a high-resolution Aβ1-42 was reported by Xiao et al. and produced by using the ssNMR 
approach.14 Interestingly, this structure was different than the U-shaped structure mentioned before; 
this new model adopted an S-shaped structure. Each chain of the model is built by three-stranded 
β-sheets, β1 (residues 12-18), β2 (residues 24-33), and β3 (residues 36-40). Later, more similar S-
shaped structures were also reported (see figure 1.2b). The unique three-stranded β-sheet structure 
drew the interest of researchers immediately. Our  previous work over molecular dynamics (MD) 
simulation, covered in chapter 3,  was applied to study the stability of Aβ1-42 S-shaped structure 
motif. This study concluded that the critical size (6 chains) is the driving force to maintain the 
motif’s stability. Specifically the hydrophobic interaction between  β2 and β3 is the driving force 
keeping the structure stable. Truncation of hydrophobic residues on C-terminal (I41 and A42) can 





on this observation, residues 41-42 are essential to structural stability. This observation could 
explain that why S-shaped Aβ1-42 cannot cross-seed the Aβ1-40, as seen  in the previous study, is 
due to the fact that Aβ1-40 does not contain the last two residues. Lacking the last two residues leads 
to a high energy barrier for cross-seeding. This also explains why the observation of S-shaped 
structure came late.  
 
Furthermore, two different 2-fold packing symmetries are proposed. The first, PSA, is packing 
between β1 sheet from each fold. Residue K16 on one fold stabilizes the structure by forming salt-
bridge with residue D22/E23 on another fold. The second, PSB, is packing between the β3 sheet 
from each fold. Contact between V40 and G38 stabilized the 2-fold packing symmetry. 15 More 
specific details can be found in chapter 3 of this thesis. The work described above not only gives 
a better understanding of the novel S-shaped Aβ1-42 but is also crucial for later work. The stability 
study introduces the idea that there is a difference in neurotoxicity between the U-shaped and S-
shaped structures, bringing up the idea of “in-register” and “out-of-register” fibril. These two types 
of fibril differ by the hydrogen bond interaction between different chains, which is important for 
the structure transferring to a β barrel structure. The β barrel is responsible for damaging cell 
membranes and generates neurotoxicity. S-shaped Aβ1-42 can go through a structural 
rearrangement from “in-register” to “out-of-register” fibril and eventually transfer into the more 
toxic β barrel confirmation. The U-shaped structure lacks this ability.16-18  The proposed packing 
symmetry PSA is also further extended from two folds to N folds to propose the ring-like models 







Figure 1.2. U-shaped, S-shaped, and L-S shaped amyloid β.19 (Agrawal, N.; Skelton, A. A., The 








Aβ amyloidosis is only one kind of amyloidosis. Thirty-seven peptides or proteins have been 
reported that can cause different forms of amyloidosis. Seven of these proteins are related to 
amyloidosis in the central nervous system, and these amyloidosis can cause neurodegeneration, 
and lead to diseases, such as Alzheimer’s diseases and Parkinson’s diseases. Fifteen of the 
remaining thirty proteins are highly related to the amyloidosis that occur in tissues which include, 
but are not limited to, the liver, spleen, kidney, and heart. Amyloidosis in tissues is classified as 
systemic amyloidosis.1 Recently, research is mainly focused on neurodegenerative amyloids. The 
number of patients with neurodegeneration disorder is higher than systemic amyloidosis; however, 
many more cases and various tissues are involved with the latter group. 1 Understanding the 





forms of systemic amyloidosis are mentioned in this thesis, the focus of the thesis is AA 
amyloidosis which is a systemic amyloidosis triggered by the precursor protein serum amyloid A 
(SAA). 
 
At room temperature SAA adopts a disordered structure. As the temperature cools to 4 oC, and salt 
begins precipitating, the ratio of α-helical increase significantly. 20-22  All-atom structures of human 
SAA1 has been resolved by X-ray experiment. The monomer is made up of four helices together 
as a bundle and wrapped by a long C-terminal tail.  Helix 1 to 4 and the C-terminal correspond to 
residues 1-27, 32-47, 50-69, 73-88,  and 89-104 respectively (see fig 1.3a).22 Before the SAA 
monomer structure was resolved the N-terminus of SAA was previously reported as a critical 
region for misfolding and aggregation because the losing of the first 11 residues prevents 
misfolding and aggregation from happening.23 Nordling et al built a model of N-terminal helix 
with 13 residues. The structure switching between α-helix and β-harpin was observed in  
Nordling’s simulation, which consisted of previous Raman spectra measurement for SAA residues 
1-12 fragment aggregation.24, 25 Later, more simulations were conducted showing that single-point 
mutations on the Nordling’s model can cause the population shift between the helix and harpin 
conformations. 26 However, in the recently resolved structure, the N-terminal region is a long 
straight helix (residues 1-27). Compared with previous studies that all focused on the first 11-13 
residues, the neighbor helixes can affect the molecular underpinning of helix-hairpin transition due 
to the local constraint difference.  
To address what role the N-terminal helix plays in SAA amyloid formation, our work in chapter 
4, a stability study of SAA N-terminal helix I (residue 1-27) was conducted using replica exchange 





(ME-REMD). REMD is a widely used enhanced sampling algorithm that can solve the problem 
of slow sampling caused by the significant barrier in the energy landscape compared to MD. 
REMD alleviates slow sampling by exchanging replicas at different temperatures. High 
temperatures can easily overcome the energy barrier. In contrast, the low temperature can explore 
low energy conformations. REMD works well for relatively small systems; it is cumbersome for 
the proteins in explicit water. ME-REMD is an in-house modified approach that can improve the 
acceptance vanishing limitation of REMD caused by the increasing system size. If the number of 
replicas stays the same, the exchange rate will significantly decrease. REMD and ME-REMD will 
are discussed in detail in chapter 2. Comparison of simulation data from REMD and ME-REMD 
reveals the physical properties of the system, such as secondary structure probability, the outcome 
of ME-REMD consists of REMD. ME-REMD can maintain the same exchange rate between 
replicas by reducing one-fourth of the replicas comparing in REMD, due to this property of ME-
REMD, it has the potential to be applied on more extensive systems to save computational 
resources. Using ME-REMD allowed us to explore three motifs of SAA N-terminal helix: 1) the 
straight helix, 2) the helix hairpin, and 3) the N-terminus dynamic. The straight helix maintains a 
similar helix structure as crystal structure. The helix hairpin more than 50 % of the straight helix 
break in the region of residues 11-13, and the two sub helixes form a hairpin shaped structure that 
is maintained through the hydrophobic interaction between two helixes. The N-terminus dynamic 
is the first helix of the helix hairpin motif to loses its structure. This is due to disruption of the salt-
bridge between R1 and E9 which normally maintains the first helix in a stable state. The N-
terminus dynamic motif could be the starting point for the first 11 residues to misfold into a β-
hairpin and the potentially forming aggregates. Mutation E9A can disrupt the salt-bridge between 





observation is consistent with previous reported SAA shorter fragment simulation studies. 26 
Although the mutation E9A is not observed in nature, the mutation changed the isoelectric point 
of the SAA fragment and mimicked an acidic condition. The increasing probability of misfolding 
and aggregating is consistent with experimental observations under low pH conditions. Our work 
on the N-terminal SAA resulted in the proposed mechanism that the key residues maintain the 
stability of the critical region and prevent it from misfolding and aggregating.  
 
 
Figure 1.3. a). Monomer, and b). hexamer of serum amyloid A.1 (Westermark, G. T.;  Fändrich, 
M.; Westermark, P., Annual Review of Pathology: Mechanisms of Disease 2015, 10, 321-344. 
Copyright 2015 by Annual Review of Pathology, see details in Appendix IV) 
 
 
1.4. Downregulation and Amyloid Formation Mechanism of SAA 
 
While misfolding and aggregation are a trigger, they do not absolutely lead to the diseased 
condition. The human body has protective mechanisms against the misfolding and aggregation of 
proteins, when these mechanisms fail the diseased conditions happen. 27 It is not only essential to 
understand the misfolding and aggregation process, but also the protective mechanisms; however, 





mechanisms is not clear, the factors that are known to play essential roles during the process, are 
precursor protein concentration, genetic mutation, cleavage, binding to other molecules, and 
seeding. As mentioned before, more than 30 proteins have been found related to amyloidosis, and 
while the amyloid formation mechanisms can vary for different proteins, several features are  
common among all proteins: the nucleus formation and fibril elongation fibril. 28 On the other hand, 
the protection mechanisms might also include standard components among different proteins; 
understanding these components can offer more precise treatments. Individual proteins need to be 
researched to recognize these crucial features and eventually the profiles can help us find the 
pattern. In this thesis, SAA monomer and hexamer fragments are studied to answer this question.  
 
Previous studies have shown that SAA oligomeric states are not limited to one structure;  hexamers, 
octamers, and monomers have been identified in murine SAA2.2. A recent study of the SAA 
atomic structure has also established the full length of human SAA1.1. It was found to be a  104 
residues monomer that is assembled as a hexamer and functions as the biologically active state 
(see fig 1.3b).22  The biological function of the SAA is rarely understood. Still, some important 
functions have been identified before. For example, under certain health condition, SAA will bind 
to high density lipoprotein (HDL) and transport cholesterol away from the injured site for the 
human body to recycle later. 1 Under the condition that the human body has an infection, such as 
rheumatoid arthritis (RA), the concentration of SAA can increase to 1 mg/mL and reach to 1000 
fold higher than would otherwise be if no infection were present. With the help of 
glycosaminoglycans (GAGs), such as heparin/HS, SAA will no longer be bound  to HDL, from 






The mechanism of SAA fibril formation was proposed to happen in the following way. SAA first 
dissociates from HDL, enters the cell, and resides in the acidic lysosomal environment. Structural 
rearrangement of SAA happens in the lysosomal environment. During the rearrangement 
oligomers forms in the cell, and then the oligomer breaks the lysosomal and cell membranes 
reaching the extracellular environment. Finally, SAA oligomers extend to mature amyloid fibrils. 
29 The concentration of SAA increases up to 1000 folds during acute inflammation. However, for 
different individuals, the duration and exact levels of SSA concentrations vary. The difference in 
concentrations among patients may explain why not all patients with acute inflammation suffer 
from SAA amyloidosis. However, more importantly, the protein quality control system plays an 
critical role in the degradation of SAA and its fibril deposits. The degradation process is an 
efficient way to release the pressure of SAA overexpression. It can downregulate the concentration 
of SAA via cleavage. Failure of degradation/ downregulation can lead to the diseased condition. 
The mechanism of SAA degradation in fibril formation is not precise.  
 
Our work in chapter 5 proposes a down-regulation mechanism for SAA under disease condition. 
Down-regulation failure causes SAA fibrils formation. The down-regulation mechanism is a two 
step-process. First, under the high concentration diseased condition, SAA activity has been 
reduced via the cleavage, which can shift the equilibrium from full-length hexamer to shorter 
monomer fragments. Secondly, the shorter fragment SAA 1-76 can switch between two structural 
forms. The first form (helix-weaken) is easy to proteolyze, however, it could also trigger 
aggregation and the second form (helix-broken) is hard to proteolyze but prevents aggregation. 
These two forms are highly related to the environmental conditions such as pH. Under natural 





region and fast degradation. Inversely, acidic conditions can increase the chance of amyloid 
formation. The population shifts to helix-broken structure to protect the N-terminal region from 
aggregation. This is accomplished primarily by the salt-bridge interaction between residues R1 
and E9 being disrupted at acidic condition, which makes N-terminal region shift to a disordered 
state. However, the failure of this switching mechanism could lead to aggregation and disease 
conditions.  Our work revealed SAA downregulation and aggregation mechanism. This 
mechanism can be generated as a model to study other amyloidosis.  
 




To better understand the SAA fibril formation, mechanism we extended our work to study the 
stability of recently reported all-atomic SAA fibril structures. The structure is built by a short 
fragment (residues 2-69).  The region that contains residues 2-55 have been identified as ordered 
cross-β structure,  and the region containing residues 56-69 is classified as a disordered structure 










Figure 1.4. Fibril structure of SAA residues 2-55.30 (Liberta, F.;  Loerch, S.;  Rennegarbe, M.;  
Schierhorn, A.;  Westermark, P.;  Westermark, G. T.;  Hazenberg, B. P.;  Grigorieff, N.;  Fändrich, 




Understanding the fibril formation is difficult regardless of whether experimental or computational 
approaches are used. Our preliminary data in chapter 6 provides a potential mechanism of SAA 
fibril formation through studying the thermodynamic stability of different sizes of fibril systems. 
The subunit of fibrils with variant stability could reveal interactions that are critical for fibril 
formation. First, we identified that the crucial dimension of SAA fibril is a two-fold two layers 
system. The stacking between monomers happens first to form a meta-stable one-fold two layer 
structure which is stabilized via packing into a two-fold system. The interactions on the N-terminal 
region maintain the two-fold symmetry. Second,  acidic pH does not affect the stability of the two-
fold systems but low pH conditions can stabilize the one-fold two-layer meta-stable structure via 
altering the sidechain interaction pattern in the C-terminal cavity (forming sidechain hydrogen 
bonds). This observation indicates that acidic conditions are critical for the early stage of SAA 





11) is essential to maintain the two-fold packing and stabilize SAA fibril. The C-terminal 
disordered region (residues 56-76) does not reduce the stability of the two-fold system. Our work 
proposes a potential mechanism for SAA fibril formation. Monomers stack to form meta-stable 
structures.  
Under acidic conditions, the meta-stable states are stabilized. Then, the meta-stable structures pack 
via their N-terminal region to develop a two-fold symmetry. The C-terminal disordered regions 
did not interrupt this process. This potential mechanism can offer atomic details and insight into 
early-stage SAA misfolding and aggregation. 
1.6. Summary 
 
In summary, the scope of this thesis covered our work in studying the fibril formation of Aβ and 
SAA. Many previous studies focused on the elongation/transition phase for Aβ, however the 
elongation phase for SAA was rarely reported. Understanding the transition between native 
structure and fibril is critical for revealing mechanism of SAA amyloid fibril formation and 
provides potential guidance for drug design and treatment.  The work can be continued by applying 
state-of-art computational approaches to explore the landscape and transition pathway of SAA 









Chapter 2. Overview of Protein and Protein Folding Biochemistry 
 
 
2.1. Amino Acids and Proteins  
 
 
The amino acid is the basic unit of proteins. Around 500 different amino acids have been identified 
in nature by humans however, only 22 amino acids are related to protein formation. Of these 20 
amino acids are classified as proteinogenic amino acids. 31-33 Amino acid has a carboxyl and an 
amine group, along with a unique side chain. Based on the side-chains properties, proteinogenic 
amino acids can be classified as charged (R, K, H, D, E), polar (S, T, N, Q, C, G, P) or non-polar 
(A, I, L, M, F, W, V, Y). The remained 2 amino acids are O and U. More details about amino acids 
can be seen in figure 2.1. Combinations of these 22 kinds form the sequence of peptide chains and 
assemble into to a different proteins. Proteinogenic amino acids are all "left-handed" isomers or 
L-amino acids (L-stereoisomers), and a few D-amino acids are identified in bacteria cell walls but 







Figure 2.1. Examples of proteinogenic amino acids under physiological pH35 (Aerts, J. W., 
Röling, W. F., Elsaesser, A., & Ehrenfreund, P. (2014) Life, 4(4), 535-565. Open access journal 
and no copyright is required) 
 
 
The biochemical properties of different amino acids depend on their different side-chains. Side-
chains protonation states are highly related to the pH of the environment. Isoelectric point (pI) is 
a pH value that maintains the average net charge of zero. When environmental pH is lower than 
the pI, the charged amino acids side-chains are protonated, on the contrary, a higher value of pH 
can deprotonate them. The change of side chains protonation states can affect the biological 
functions of amino acid; for example, the protonated / deprotonated of side chains can disrupt the 







The initiation of protein formation begins with the peptide bond formation. The peptide bond 
formation is a type of condensation reaction. During the condensation, the α-carbon atom of one 
amino acid movs close to the α-nitrogen atom of the other. Two amino acids lose one oxygen and 
two hydrogen atoms. A water molecule is produced during this reaction and the peptide bond 
connects the two amino acids.37 To break a peptide bond, it requires overcoming a high energy 
barrier and releases energy of ~ 2-4 kcal/mol.  This energetically unfavorable process takes an 
exceptionally long time; at room temperature the half-life of the peptide bond is 350-600 years. 38 
This process can be accelerated by the participation of enzymes in living organisms. Peptide bond 
hydrolysis with enzymes is known as protease. 39 
 
The peptide bond is a double covalent bond. The amide group forms a planar bond and exists as 
cis or trans-isomers. The two isomers can both exist in the unfolded protein structure; however, in 
the folded structures only one isomer can be adopted in each position. Compared to cis the trans 
isomers are adopted in most of the cases (99.9 %).  One exception is Proline. In the X-Pro peptide 
bond (X means any amino acid in front of Proline) the unique side chain of Proline causes the 
energy difference between cis and trans isomer to be much less causing the ratio of cis over trans 










2.1.1 Levels of Structures 
 
Proteins are polypeptides and chains under 30 amino acids are considered to be peptides rather 
than proteins by convention. 40 Proteins fold into specific 3D structures via driving forces including 
hydrogen bonding, hydrophobic interaction, Van der Waals and electrostatic. These 3D structures 
allow the proteins to perform their biological functions. The adopted structures have a tight 
relationship with their function. Many experimental techniques, X-ray crystallography, cryogenic 
electron microscopy, and solid-state NMR (ssNMR) spectroscopy are employed to characterize 
the structures of proteins. The size of proteins range from about ten to thousands amino acids with 
the physical size being between 1 to 100 nm.  Massive aggregates can be formed by subunits, such 
as oligomers. 41 
 
Protein structure has four distinct levels (primary, secondary, tertiary, and quaternary).  Amino 
acids sequence determine the primary structure. 42 In between N- and C- terminus are residues 
connected by a peptide bond and this connection forms the backbone of proteins. The sequence of 
primary protein structures can be determined directly or from DNA sequences. Their sequences 
can often determine the primary structures of the protein. However, variant modifications can be 
involved which alter the structures such as disulfide bond cross-linking, transition between L- and 






The amino acid sequence is highly related to protein 3D structure. The local features of the 3D 
structure, such as the secondary structure segmentation, can be predicted from the sequence 
(primary structure). 3D structures of proteins cannot be determined only by its sequence. However, 
the structural information of a homologous protein increases the accuracy of prediction through 
homology modeling. 43 
 
The secondary structure of the protein is 3D local segments of protein. 44, 45 Secondary structure is 
strictly defined by the backbone hydrogen bond pattern or by using the backbone dihedral angles 
pattern. A Ramachandran plot is a method to classify the secondary structure by using backbone 
dihedral angles directly. 46 α-helices and β-sheets are most commonly observed secondary 
structures.  In an α-helix structure, backbone atoms spiral around a virtual axis. There are average 
3.6 residues in each helical turn, and a hydrogen bond ring contains 13 atoms. Compared to other 
secondary structure motifs, the α-helix is most prevalent and most natural to predict from the 
sequence.47 Other standard helix structures, such as π-helix, is less observed due to the unfavorable 
packing of the backbone atoms.  The backbone of β-strands adopted a zig-zag pattern, differing 
from the α-helix. Adjacent strands can be formed by the sequences that are far away from each 
other. β-sheets can be classified as parallel/antiparallel by the direction of adjacent strands (see fig 
2.2). β-sheets can lead to amyloid formation in human diseases. Turns and loops link other 








Figure 2.2. Secondary structure motifs. a). α-helix. b). β-sheets. N and C stand for terminus. 
  
The tertiary structure describes the protein 3D structural information. 48 The backbone of the 
tertiary structure connects one or more secondary structure motifs while the side chains of protein 
interact with other side chains. Hydrophobic interactions drive folding of the proteins. 
Hydrophobic residues are buried inside the globular structure, but further stabilization of tertiary 
structure may require stronger interaction, such as salt-bridge interactions to lock up the structure.  
Quaternary structure is a 3D structure assembled by more than two polypeptide chains; the 




2.1.2. Protein Folding and its Driving Forces 
 
From the primary structure to 3D structure, proteins go through a folding process that happens 





bond contacts. 49 The local environment, such as pH conditions, salt concentration, and 
temperature effects can profoundly affect protein folding.  
 
The fundamental driving force behind protein folding is hydrophobic interactions among side 
chains. Minimizing the side chains exposition to water can effectively increase hydrophobic 
interactions. The hydrophobic regions of protein collapse to form the hydrophobic core during 
folding process. When the protein surrounds by water, water molecules aggregate outside of the 
hydrophobic core and form a water shell which decreases the entropy. This makes the folding 
process favorable to entropy. Inside the hydrophobic core there are van der Waals interactions 
among these hydrophobic groups and hydrogen bonds which significantly increase the stability of 
protein after folding. 50, 51 The distribution of hydrophobic residues can determine if a primary 
sequence can fold into a protein with globular structure, random distribution, or cluster of 
hydrophobic residues because they can disrupt the folding process causing the protein to adopt an 
intrinsically disordered structure. 52-54 
 
Protein function is determined by its structure and structure highly depends on folding. The 
theoretical understanding of protein folding remains incomplete. An energy landscape can describe 
the conformational space of protein folding. Bryngelson and Wolynes proposed that due to the 
principle of minimal frustration proteins, nature already has optimized energy landscapes for 
folding.55 The natural evolution determines the specific primary sequence of the protein making 
the folding process faster and native structure is sufficiently stable. Although the frustration has 
been minimized for proteins, some left-over cases can still be observed as local minima. The 





through more than one pathway towards the native structure at the bottom (see fig 2.3). 56 The 
model has been proved very powerful to explain the experimental and simulation data. 
 
 
Figure 2.3. Sketch of the funnel-shaped free energy landscape. 57 (Chong, S. H., & Ham, S. 
(2019). Scientific reports, 9(1), 1-9. Open access journal and no copyright is required) 
 
Proteins are not guaranteed to fold into their native structures. Misfolding can be triggered by 
amino acid sequence mutations or external factors that can disrupt the folding process. 58, 59 β-
sheets are often involved in protein misfolding, and β-sheets can be clustered and arranged into a 
stable cross-β structure via the backbone hydrogen bonds. The cross-β structure is highly stable 
and insoluble which allows the protein to protect itself from proteolysis. The misfolded protein 
can further aggregate into oligomers and amyloid fibril structure and eventually cause cell death. 60 
 
2.2 Protein Misfolding Disease: Amyloidosis 
 






Amyloidosis are diseases caused by the protein misfolding and aggregation into abnormal fibril 
deposition. The abnormal fibril depositions are triggered by different factors, such as mutation or  
cleavage of the precursor protein. 1  
 
Formation of amyloid fibrils is characteristic of amyloidosis; examples of this include amyloid β 
fibrils which originate from the precursor protein of Aβ amyloidosis, or SAA fibrils which 
originate from the precursor protein of AA amyloidosis. The two proteins have significantly 
different primary, secondary, and tertiary structures; however, they eventually can form amyloid 
fibrils that have uniformed structure. The structure can be observed by the electron micrograph of 
tissues or in vitro samples. The fibril structure is typically made up by a single or several 
protofilaments. It appears straight and unbranched. The lateral width (~ 10 nm) of the single fibril 
is highly consistent among different precursor proteins. 61, 62  The cross-β structure is the 
fundamental structural component of the amyloid fibril. 63 The structure is formed by the interchain 
interaction between β strands. 61 The Cross-β structure can be determined by different experimental 
techniques. For example, X-ray diffraction can measure a pattern of cross-β structure which 
contains two reflection signals at ~ 4.7 angstroms and ~ 8-12 angstroms. The first one is relatively 
sharp compare to the second. 61 The structure also can be stained by Congo red and thioflavin S. 
Dyes can be used to diagnose amyloidosis. 
 
Amyloid fibrils can adopt a similar cross-β structure regardless of the difference in precursor 
proteins that they are derived from. This cross-β structure suggests that a general mechanism is 
possible for amyloid fibril formation. A nucleation-dependent aggregation mechanism has been 





two essential phases, the nucleate formation and fibril elongation. During the nucleate formation  
oligomers are assembled by unstructured soluble monomers. High energy barrier needs to be 
overcame for oligomers forming. This forming process is rate-limiting and the oligomers at this 
time are in a so-called "fluid-like" disordered structure. When it approaches to a critical size, the 
disordered oligomer rearranges its structure into more organized oligomer that is rich in β-sheets.72, 
73 This structural rearrangement produces protofilaments. Unlike the nucleation phase, the 
elongation phase is a more energetically favorable process. During this process more and more 
monomers are extended to the protofilaments via a "dock and lock" mechanism, the elongated 
protofilaments form protofibrils and that then develop into mature fibrils. 68 
 
2.2.2. Amyloid β Amyloidosis 
     
In this thesis two different amyloidosis (Aβ and AA amyloidosis) are discussed in detail and many 
other amyloidosis are referenced. Aβ amyloidosis is a result of amyloid β (Aβ) peptides 
aggregation, it can lead to Alzheimer's disease (AD). AD affects more than ten millions of people 
across the world and causes substantial social and economic burden with its dramatically fast-
growing numbers.74-76 Aβ peptides are segments of amyloid precursor protein (APP) caused by 
proteolytic cleavage. 77  APP can be sequentially cleaved by α-secretases and γ-secretases, which 
generates the P3 peptide that is non-pathogenic, or by β-secretases and γ-secretases, which can 
generate a pathogenic Aβ peptide. Aβ peptides have different length because γ-secretases do not 
cleave at the same location absolutely. The most common variants are 40 (Aβ 1-40) and 42 (Aβ 1-
42) residues long peptides. Aβ 1-42 contains two more hydrophobic residues at the C-terminal region, 





An Aβ monomer is termed as an intrinsically disordered protein (IDP) due to its structural 
flexibility in an aqueous environment. Aβ monomers have the ability to adopt multiple 
conformations.81, 82 The structures of Aβ monomer are mainly determined using ssNMR and 
computational simulation, such as molecular dynamics (MD). Under a membrane-like 
environment, Aβ1-40 and Aβ1-42 monomers adopted structures that contain high α-helix content. 
For example, the Aβ1-42 monomer has two helix regions (residues 8-24 and residues 28-38), and 
the two helixes are linked by a turn region (residues 25-28).83, 84 However, a significant loss of 
helix content in the aqueous environment has been observed. The Aβ monomer in water solvent 
has the lowest helix content. Due to the IDP property of Aβ monomer peptides, MD simulations 
are employed to measure the structural information of Aβ monomer systems in both aqueous and 
membrane environments.85, 86 For example, the replica-exchange molecular dynamics study of 
Aβ1–40 and Aβ1–42 monomers have shown that the N-terminal region of monomers is famous for 
misfolding and aggregation while C-terminal regions favor membrane-like environment.87 
Aβ oligomers are intermediate states that form before the mature fibril. Among different Aβ 
structures Aβ oligomers are the most toxic.88-92 Few structures have been determined through 
experimental approaches due to its unstable nature. 93 The mechanism of Aβ oligomers 
neurotoxicity is not fully understood. Three primary mechanisms have been proposed: the creation 
of pores that disrupt cell membranes, membrane structure perturbation, binding with the receptors 
on the membrane surface.93, 94 
Unlike the highly insoluble structures of Aβ oligomers, Aβ fibrils adopt a uniformed cross-β 
structure. 61, 95, 96 Early ssNMR studies have shown that each chain of fibril adopts a turn region 





and a hydrophobic core is formed in between the β-sheets. 97, 98 Multiple driving forces are 
involved in keeping the U-shaped structure stable. The first is an interchain backbone hydrogen 
bond between adjacent chains. Secondly, van der Waals interaction are observed in the 
hydrophobic core.  And thirdly there is salt bridge interaction in between residues Lys28 and 
Asp23. 99, 100 In 2015, an S-shaped fibril structure of Aβ1-42 was revealed using ssNMR. This 
structure was different from the U-shaped structure which contains three β-sheets. Instead of 
relying on the salt bridge interaction between residues Lys28 and Asp23 for stabilizing the 
structure, S-shaped fibril relies on the hydrophobic packing between the last two residues and 
nearby β-sheet. Interestingly, unlike the U-shaped structure, only Aβ1-42 S-shaped structure was 
observed. Simulation results showed that the S-shaped structure can shift between "in-
register"  and  "out-of-register" fibril and eventually transforms to a β-barrel structure which can 
disrupt membranes; this may explain why Aβ1-42 is more toxic. In a more recent cryogenic electron 
microscopy (Cryo-EM) study, an "L–S" shaped Aβ1-42 structure has been reported.  In the "L–S" 
shaped structure, L-shaped at N-terminus and S-shaped at C-terminus. The structure is stabilized 
through hydrophobic interactions among three hydrophobic clusters.101 More and more structures 
will be resolved with the improvement of experimental characterization. The same sequence of 
amino acids of Aβ protein can lead to different fibril shapes, the polymorphism cause different 
interaction sites, and these sites give different properties of fibril surface, which may affect their 
cellular toxicity. Regardless of different topologies of structures, understanding the factors that 






In recent years, more knowledge of Aβ structures has been accumulated through different 
experimental techniques. However, more works are still needed in understanding the early stage 
of misfolding and the mechanism of neurotoxicity caused by Aβ oligomers/fibrils.  
          
2.2.3. Amyloid A Amyloidosis 
 
The typical systemic amyloidosis is called AA amyloidosis. AA amyloidosis a byproduct of the 
primary disease, such as neoplastic, chronic inflammatory, and infectious diseases.  Under the 
primary disease conditions, the precursor protein SAA get overexpressed and approached a 
concentration that is 1000 times what the average concentration is. This crowded environment 
provides the SAA with the opportunity to misfold and aggregate.   
SAA is highly conserved among different species, but we will use the SAA nomenclature here to 
represent proteins in the human system. There are three individual members, includes SAA1, 2, 
and 4. Different genes encode them.102 SAA 1 and 2 are mainly expressed in the liver, and SAA 4, 
is expressed in tissues. SAA 1 and 2 are classified as acute-phase proteins that can bind with high-
density lipoprotein (HDL) in plasma. The production of SAA is under the control of cytokines, of 
which the most important is IL-6.103 The structure information can be seen in fig 1.3. This 
arrangement of the structure may also help to keep N-terminal stable due to N-terminal has been 
proved critical for amyloidosis. However, the structure of SAA binding HDL is still not known. 
Not only SAA, but many amyloid fibrils are built by shorter fragments rather than full-length 
precursor protein. Cleavage of the parent protein can expose the hidden regions in the native 





high local concentration. The full-length SAA in humans has never been observed to form 
amyloids in humans. However, shorter fragments of SAA that miss the C-terminal region can form 
fibril in vivo. The length of the fragments start from a few residues to more than 50 residues. With 
the cleavage on C-terminus, the N-terminal region is free to transfer to β-sheet structure. 22 
The mechanism of SAA released from HDL is unclear. Increasing levels of HSPG may be critical 
for SAA and HDL dissociation. This is concluded from the observation that heparan sulfate (HS) 
can dissociate SAA from HDL. 104 Strong evidence have shown that macrophages in the 
reticuloendothelial system are critical to the SAA dissociation process. 105 Previous studies also 
reveals that the early stages of fibril formation happens in lysosomes when SAA is endocytosed. 
The C-terminus is truncated and the N-terminus is misfolded by the lysosome/cell causing 
intracellular oligomers to appear and disrupt the lysosome and cell membrane. This releases the 
protein into the extracellular environment where it is assembled into fibril structure (see figure 
2.4). 29 
 
Figure 2.4. Formation of SAA fibril. 1). SAAs are endocytosed into cells. 2). Intracellular 
nucleation. 3). Intracellular leakage. 4). Cellular clusters formation. 5). Release to extracellular 
space. 6). Extracellular growth.29 (Claus, S.;  Meinhardt, K.;  Aumüller, T.;  Puscalau‐Girtu, I.;  
Linder, J.;  Haupt, C.;  Walther, P.;  Syrovets, T.;  Simmet, T.; Fändrich, M., EMBO reports 2017, 






Enzymes play an role in degradation and SAA fibril formation. The SAA amyloid formation can 
be accomplished in a short period with cleaved monomer. This observation indicates that cleavage 
is critical for SAA fibril formation. A previous study indicates that the lysosomal pathway 
degrades SAA. This degradation may be overloaded when local SAA concentration is too high. 106 
Cathepsin B, a protease in the lysosome, can cleavage SAA to the most common 76 residues long 
fragment for amyloid formation. 107 In the extracellular environment there are metalloproteinases, 
MMP1, MMP2, and MMP3 that can interact with SAA protein. MMP3 can cleave SAA into 
shorter fragments for aggregation. 108, 109   
As mentioned before, full-length SAA is not a notable species in SAA amyloid formation. In this 
case understanding the importance of cleavage seems critical to SAA fibril formation. Until 
recently the role of cleavage for SAA was unclear. Our work has shown that the cleavage is critical 
for shifting the equilibrium of SAA hexamer to a monomer which reduces the pressure caused by 
overexpression during the acute phase reaction in responding to the primary diseases; the monomer 
fragments, can later be degraded by Cathepsin D in the lysosome. The Cathepsin D can cleave the 
SAA fragment on the N-terminus and this cleavage can protect shorter fragments from aggregation. 
However, this degradation may be overloaded and causing it to eventually fail and this in turn 
causes intracellular aggregation. 110 
Recently, murine and human SAA fibril all-atom structures have been resolved via cryo-EM, (the 
human AA fibril was collected from a patient's kidney). The human fibril is made from the SAA 
fragment (residues 2-55) and the disordered region (residues 56-69); this disordered region is 





structure. The packing interface between two folds is large and contains ionic, polar, and 
hydrophobic interactions as well as two layers to maintain a stable fibril structure. Studying the 
structure-property of fibril is critical to understand the fibril formation mechanism needed to 
provide insight into prevention/treatment development. 
2.3. Simulation Methods 
 
The majority of determined protein structures are collected in a protein data bank. They are 
determined by using a different methods such as X-ray diffraction crystallography, cryo-EM, and 
solid-state Nuclear Magnetic Resonance (ssNMR). 111-114 The structures are valuable and essential, 
but it is hard to get dynamics information from them. Interactions between proteins depend on the 
types of interactions. They happen on time and size scales, which are hard for the experimental 
methods to measure and observe. In order to capture the protein interactions in microsecond 
timescales and under atomistic resolution computational methods seem to be an excellent tool to 
be employed here.  
 
2.3.1. Molecular Dynamics (MD) 
 
Molecular Dynamics (MD) is an offen used approach for protein structural prediction. MD can 
output realistic trajectories by using the Newtonian equation. The Born-Oppenheimer 
approximation of nuclear motion are assumed in MD, quantum effects are ignored, and  each atom 
is defined as a point of mass. 115 The relationship between the mass of atom i, and its position 𝑟! , 
can be described by equation 2.1, where 𝑝! stands for the momentum, 𝑚! 	stands for the mass of 












The net force 𝐹! which is applied on atom i is calculated by using a potential energy function (d𝑉)  















Where 𝑟! is a three-dimensional vector stands for atom i position in x-, y-, and z-direction. For 
example, x(t) stands for at time t the x-coordinate  of atom i. Using the standard Taylor series the 
position along x-direction in next concise time interval can be calculated by equation 2.4. 116 
 
 












𝑥(𝑡) stands for a position,  #$(&)
#&
 for velocity and #
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 for acceleration. Higher terms of the Taylor 
series expansion can be considered as 0 and the acceleration can be connected to mass and force 







If the atom i’s position in direction x at time t and before t have already been understood, 
integration algorithms can be applied to get the position after the next 𝛿𝑡 time interval. One famous 
integration algorithms is the Verlet algorithm. Using Verlet, with the positions at time t, 𝑡	 − 	𝛿𝑡, 
and 𝑡 + 	𝛿𝑡 is calculated using equation 2.6. 116 
 
 






The Verlet algorithm gives the position data using equation 2.7 and velocity data using equation 
2.8. 116 
 










𝑣$(𝑡 + 	𝛿𝑡) = 	𝑣$(𝑡) +
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2.3.2. Force Field Potentials 
 
From the Verlet algorithm we can see that the position and velocity of atom at a particular time 
depend on the force applied on an atom. The force is determined by potential energy calculation. 
In MD the potential energy calculation is done using a force field. Many force fields are proposed 
and refined for accurate prediction of proteins. Here, CHARMM27, one of the most studied force 
fields, is utilized. To illustrate how potential energy is calculated using force fields, the potential 
energy equation can be seen in equation 2.9. Both bonded energy and non-bonded energy 
contribute to the potential energy. 116, 117 
 
𝑈()*+,, =	𝑈-./#0# +	𝑈/./-./#0# 						(2.9) 
 
The bonded energy term includes bond stretching, bond angle bending, a "Urey-Bradley" term, 
dihedral energy term, improper dihedral energy term, and cmap term. They can be seen in equation 
2.10. 117 
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𝑈-./#<  is the term that defines the bond stretching, the force field constant 𝑘-  and 𝑏;	(naught 
values) are taken from force field parameters. 𝑈1/230 is the term that defines the angle bending, 
the force field constant 𝑘= and naught values are taken from force field parameters. 𝑈45 is the so-
called "Urey-Bradley" term which is an addition to 𝑈-./#< and 𝑈1/230. The term is introduced to 
angle term in some cases during the vibrational spectra optimization; the force field constant 𝑘45 
and naught values are taken from force field parameters.  𝑈#!60713 is the term that describes the 
dihedral angle, periodicity parameters n, phase shift parameters delta, and the force field constant 
k are taken from force field parameters.  𝑈!897.907  is the term that describes the out of plane 
dihedral angle, the force field constant 𝑘A and naught values are taken from force field parameters. 
𝑈(,*: term is a correction for dihedral angle values on the backbone. It is used to improve protein 
backbones' conformational properties. 117 
 





























The Lennard-Jones potential term is defined using the first term of equation 2.13. It describes the 













stands for the 
attractive long-range term between atom i and j. 117 
The electrostatic potential is a function of electrostatic interactions between pairs of charged 
atoms. Due to the non-uniform distribution of charges for some molecules, one way to solve this 
in MD is to assign partial charges to the center of mass for both atoms.  
 
2.3.3. Replica Exchange Molecular Dynamics (REMD) 
 
According to the funnel-shaped energy landscape, while a protein is searching for its native 
structure it could become trapped in local minima. Although MD can provide the physical 





trapped in the free energy local minima. In order to solve this problem, replica exchange molecular 
dynamics (REMD) was proposed to increase sampling efficiency. REMD alleviates slow sampling 
by exchanging replicas at different temperatures. High temperature can easily overcome the energy 
barrier while the low temperatures can explore the low energy conformations. In REMD, under 
different temperatures, multiple MD simulations run simultaneously for one same system; the 
distribution of temperature is from low to high. MD simulations under different temperature are 
replicas. Replicas get their configurations swapped with the neighbor replicas by velocities 
reassignment if a Metropolis criterion is satisfied. 𝜋I" stands for the Boltzmann distribution of 
replica under temperature T. Temperatures distribution optimization is critical for REMD 
simulation to be successful. 
     
   	











The Metropolis criterion is satisfied. The metropolis criterion is given below  
 
min^	1,
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To summarize, this chapter provides the biochemical background of proteins and protein folding 
and presents the protein folding process from a theoretical aspect. Under the situation of misfolding, 
the misfolded peptides can aggregate into amyloid fibrils. The fibril is further deposited in tissues 
and organs and it is this abnormal deposition that can cause diseases related to amyloidosis.  
Amyloidosis can become either local or systemic depending on the position of fibril deposition. 
Different forms of amyloidosis is generally triggered by different precursor proteins misfolding 
and then aggregating. Understanding the misfolding or amyloid formation is essential as it can 
offer guidance for treatment development for related diseases. Studies always start with the 
structures of precursor proteins. Experimental approaches have provided crucial high-resolution 
information for these structures; however, the experimental approaches cannot reveal the dynamics 
or critical interaction of the structure as the time scale of these interactions is smaller than 
experimental approaches can measure. Computational approaches are more suitable to answer 
these questions. An overview of selected modern simulation methods is given, and exactly how 





















The material in chapter 3 is adapted from Xi, W., Wang, W., Abbott, G., & Hansmann, U. H. 
(2016). Stability of a recently found triple-β-stranded Aβ1–42 fibril motif. The Journal of Physical 
Chemistry B, 120(20), 4548-4557. The copyright permission is obtained from, see details in 
Appendix IV.  
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A growing number of human diseases are correlated with the presence of amyloid fibrillar 
plaques118-120, visible under ultraviolet light after staining with Congo Red.121 A prominent 
example is  Alzheimer’s Disease122, a neurodegenerative disorder that is the leading cause of senile 





peptides.124 Most common are the  Aβ1-40 and Aβ1-42 species, with the Aβ1-42  more toxicity than 
Aβ1-40.125 While the insoluble amyloid plaques are neurotoxic, there is evidence that solvable 
oligomers (which  could be either on the fibril formation pathway or off-pathway)  are  more toxic  
than the mature fibrils.126, 127  The self-assembly of Aβ peptides leads in vitro  to polymorphic 
oligomers and fibrils  that share a cross-β sheet packing.128-132  The differences in molecular 
structure between these amyloid  polymorphs is correlated with the speed of disease progress.132, 
133 Hence, for the purpose of deriving and evaluating treatment options it is important to understand 
the details of amyloid formation, especially of the process that selects  specific polymorphs. An 
example is the seeding and acceleration of the prolongation of new fibrils by pre-formed fibril 
fragments.134 Such fragments can not only seed proteins and peptides of the same kind but also 
different amyloidogenic molecules. For instance, Aβ1-40 fibrils can cross-seed  Aβ1-42 fibrils and 
vice versa.135  This effect is known as cross-seeding,136 and may explain the statistically observed 
correlations between occurrence of  certain amyloid diseases.137 For example,  Aβ1-40 and Aβ1-42 
can seed in vitro  other amyloid peptides such as hIAPP (amylin) implicated in type II diabetes. 
135, 138-141 Similarly, there is evidence that some of the  Aβ-amyloid polymorphs  induce  conversion 
of amyloids with different structure to their  own form,  and in this way seed their own growth. 
This gives rise to the idea that  some polymorphs can act as  “infectious strains'' in patients, which 
may also explain why no polymorphism is found in fibril taken  from Alzheimer patient brains.142-
144  
 
An understanding of the role polymorphism in the pathology of Alzheimer disease requires 
therefore a characterization and comparison of such forms. A number of fibril structures have been 





two β-strands connected by a loop region.145 For instance, in one model are the two β-strands  
formed by  residues 9-23 and 31-30 and connect without a  without salt-bridge holding them 
together. The fibril has two-fold packing symmetry with the chains in contact through the  β2-
strands.130 Another model of Aβ1-40 has three-fold packing symmetry of the chains, with each chain 
made of two β-strands of residues 12-19 and 31-38 connected by a loop.132 For a long time, only 
low-resolution Aβ1-42 fibril structures had been known, which indicate the presence of  the same 
U-shape motif, with two β-strand: residues 18-26 and residues 31-42 connected by a loop, and the 
arrangement stabilized by salt bridges between residues D23-K28.129 However, using ss-NMR Y. 
Xiao et al146  have determined recently  a high-resolution   structure  for wild type homogenous 
Aβ1-42 fibrils that has a  different morphology. This Aβ1-42 fibril structure is not build out of U-
shaped chains, but each peptide forms a three-stranded  β-sheet with strands β1 made of residues  
12-18, β2 of residues  24-33, and β3 of residues  36-40. An intra-chain salt bridge between side 
chain of residue K28 and the main chain residue A42 that is not seen in previously found structures 
connects the β2 and β3 strands. While the newly found fibril motif  can seed  Aβ1-42  chains, it 
cannot seed  Aβ1-40 peptides. Xiao et al have speculated that this is because the salt bridge  K28-
A42 cannot be formed in Aβ1-40 peptides, i.e. that the stability of the newly found structure depends 
on formation of this salt bridge.146  
 
The striking difference in structure and seeding properties between the newly found form and 
previously known Aβ fibril structures opens up a new opportunity to study the mechanisms that 
lead to formation of distinct polymorphs. As the process by that fibrils form is difficult to follow 
in either experiment or simulation, such investigations best start by investigating the 





have looked into the stability of the previously found fibril forms147-149  to the newly found triple-
β-strand motif of Aβ1-42 fibrils, we hope to identify the mechanism that leads to the differences 
between the various forms. For this purpose, we focus on the following questions: first, what is 
the driving force of stability in this triple-β-strand conformation? Second, what is the relation 
between the truncation of last two residues and the mechanism of cross-propagation barriers? 
Third, do protofibrils made out of   Aβ1-42 chains with this new motif have a single-fold or two-
fold packing symmetry. Our  molecular dynamic simulations allow us to identify a critical minimal 
size for of six chains such fibril fragment. We find a surprising stability for the β2-turn-β3 motif 
even in simulations with substantially raised temperatures. The triple-β-strand motif of Aβ1-42 
fibrils remains stable even in mutants where the K28-A42 salt bridge cannot form. However, 
truncation of last two residues leads to the exposition of the hydrophobic core in the U-shape motif 
and results the disruption of the conformation. Hence, cross-seeding of Aβ1-40 fibrils is not so much 
inhibited because the K28-A42 salt bridge cannot be formed but because of the  difficulty to form  
in Aβ1-40 peptides the well-packed hydrophobic core of the β2-turn-β3 motif  that is seen in the   
Aβ1-42  triple-β-strand motif. Our simulations also suggest that the   Aβ1-42  with the newly found 
structure  will likely arrange in  fibrils with a two-fold packing symmetry, with the chains packing 
at their  β1 chains. 
 
3.2. Materials and Methods 
 
3.2.1. Fibril Conformations 
 
In order to test the stability of the newly found triple-β-strand motif of Aβ1-42 fibrils   and the forces 





in Protein Data Bank ensemble (PDB identifier: 2MXU). As the first ten residues are flexible, this 
model describes only fibrils of Aβ11-42 fragments. In order to exclude the possibility of a bias in 
our data resulting from excluding these first ten residues, we perform also as a control a simulation 
of the fibril structure for the full-length peptide Aβ1-42 with the first ten residues  forming a β-
strand. Fibrils of different size, ranging from four to seven chains are simulated at the physiological 
relevant temperature of 310 K, and these simulations suggest a critical size of five to six chains. 
Hence, in most of our simulations we considered fibrils formed by five chains. Besides the wild 
type we also study fibril fragments of this size with the  mutation K28A,or such where  the last 
two residue have been truncated (i.e. fibrils of Aβ11-40). In order to study the possible conformations 
of two-fold-symmetric fibrils, we have constructed two  assemblies differing in the packing 
surfaces between the two parts. As the  β1-strand and the β3-strand are potentially exposed to the 
solvent, we assume that  the chains  will associate at the surfaces formed by these strands, and that 
the packing surface are either between hydrophobic residues or between oppositely charged 
residues. Ten different initial states with β1- β1 association, and ten states with β3- β3 packing, 
have been constructed by optimizing the inter-chain contacts. The ten initial states of each 
arrangement are followed over short molecular dynamics simulations 10 ns length and tested for 
their stability. The most stable configurations are used for as start point of our simulations and 
shown in Fig. 3.6 for both arrangements.  
 
3.2.2. Simulation Protocol and Data Analysis 
 
Our molecular dynamics simulations are carried out in an isothermal−isobaric (NPT) ensemble 
using the GROMACS 4.5.7 software package150 with the amber ff99sb-ilde force field151 and   





while the water geometry is constrained with the SETTLE algorithm154,  allowing for an 
integration time step of 2 fs. Electrostatic interactions are calculated with  the particle mesh Ewald 
(PME) method and  a real space cutoff of 1.0 nm.155 The cutoff for van der Waals (vdW) 
interactions is 1.4 nm. Solute and solvent are  coupled separately to external temperature and 
pressure baths using, respectively, v-rescale156 thermostat and Parrinello−Rahman barostat157. 
Most of the simulations are at a temperature of 310 K and a pressure of 1 bar, but we also study 
some of our systems  at temperatures of 330K, 350K, 375K and 400K,  Each system us followed 
over  at least four trajectories that start from slightly different initial states. Each trajectory is 
followed for at least 200 ns, and for fibril fragments with either five or six chains is one of the 
trajectory extended up to  500ns. In order to allow the systems to thermalize, we omit the first 50 
ns  in each trajectory. Cluster analysis of the remaining trajectory is used to identify representative 
conformations. The binding energy are analysis with the MMGBSA tools158 in the Amber 12 
software package159 where the generalized Born (GB) model developed by H. Nguyen et al is 
employed to estimate the solvent effect.160 This procedure leads to an estimate for the binding free 
energy given by:  
 
where  Eelec is the electrostatic  and Evdw van der Waals interaction energy  in gas phase. EGB is the 
Generalized-Born approximation of the  polar solvation energy,  and Esurf  is non-polar solvation 









3.3. Results and Discussion 
 
 
3.3.1. Stability of Aβ11-42 Fibrils with the Triple-β Motif 
 
In order to analyze the stability of the newly-found Aβ1-42 fibril structure with its triple-β-motif,  
we determine first the minimal size of Aβ11-42 fibril fragments with this structure. For this purpose, 
we have simulated suitable fragments with either four, five, six or seven chains, with the start 
configuration taken from the Protein Data Bank  (PDB id: 2MXU) as shown in Fig. 3.1a. The root 
mean square distances (RMSD) to the corresponding initial conformation (build from the first 
entry of the ssNMR ensemble as deposited in the Protein Data Bank) are shown in Fig. 3.1b as 
function of time. For each of the systems we have generated four trajectories, and Fig. 3.1b shows 
these trajectories where the root-mean-square deviation after 200 ns was maximal. Over the whole 
200 ns   are  the root-mean-square deviations of the fragments with four chains (black) or five 
chains (red)  larger than the corresponding values of the systems with six (blue) or seven (pink) 
chains. This size depends is due to the larger relative weight of end chains in the smaller fragments,  
as  end chains are more flexible and  lose their secondary structure  more easily, see Fig. 3.1b. We 
also note that the β1-strands (12-18) are more flexible than other parts of the chains, especially for 
the fragments with four or five chains (Fig 3.1c).  In order to check the robustness of our results 
we have for the systems with five and six chains the simulations extended up to 500ns. 
Representative final conformations are shown in Fig. 3.1c. Note, that between 200 ns and  500 ns 
the root-mean-square-deviation of the five-chain-system (red line) continues to rise while the 
system with six chains (blue line) appears to approach a plateau, Some of the β-strands have 
dissolved in the final conformation of the five-chain system while all are preserved in the six-chain 





β-motif is  about six chains, with the fibril fragment size of five chains right on the  boundary 
between stable and unstable. Hence, most of our simulations are based on systems with either five 
or six chains. Note that with five to six chains the critical size of the Aβ11-42 fibrils with triple-β-
motif is larger than that of earlier found Aβ wild type fibril structures. For instance, the critical size 
for the previously found low-resolution Aβ11-42 fibril structure 2BEG  is three to four chains.161 
The larger critical size may indicate a higher free energy barrier for forming fibrils with the triple-
β-motif than seen in the previously found fibril structures with U-shaped chains, which could 
explain why this motif has not been observed earlier. 
 
 
Figure 3.1. (a) The initial state of a system with five chains as used in our simulations. (b) The 
rmsd of fibrils, followed  over  500ns; (c) representative conformation of the final configurations 






In the initial configurations as build from the PDB configurations, all chains are  in a periodic 
arrangement without twist in the β-strands.  Such lack of twist has been seen also in other models 
of   Aβ1-40 fibrils129, 130, 132, however,  for these models did the β strands always  acquire a twist 
over the course of   molecular dynamics simulations.149, 161, 162  This is different for the  β2 and β3 
strand of the new Aβ1-42 fibril model  which  both do not develop a twist during 200 ns of 
simulation. At the end of the respective trajectories these two strands have a twist of less than 1 
degree per chain, unlike the β1-strand which behaves more as expected and develops a twist of 
about 3 degree per chain.  As far as we know, this is the first time that such lack of twist as here in 
the  β2  and β3 strands has been seen in atomistic molecular dynamics simulations of Aβ fibrils. 
As the energy of  β-strands  is more favorable if the strands have a slight twist of about 3-5 degree 
per chain, the lack of twist implies that strong  packing interactions must compensate for the 
unfavorable backbone interactions that result from lack of a twist. Note that the secondary structure 
(as measured by the do_dssp tools163 in GROMACS) is maintained during the 200 ns  albeit the 
edge chains lose their  β1 strand (data not shown). The lack of twist implied that single-fold  Aβ1-
42 fibrils with the  triple-β-motif  would vary over 45 nm between five and six nm, while with 
twisted strands one would expect that the diameter variations happens on a length scale of 15 nm.  
 
Previous experiments have shown that the first 15 residues of Aβ1-42 are coiled without taking an 
unique conformation.129 Other work showed  that the first 8 residues of Aβ1-40 are flexible.130 In 
the new Aβ1-42 model, the first 10 residues are also considered disordered,  and are therefore 
omitted in  our simulations. In order to exclude the possibility that this omission skews our data 
we have  performed simulations with a model where we have added these first ten residues,  





strand dissolves over the length of the simulation and the first ten residues line up as a disordered 
flexible segment. However, the addition of these additional N-terminal residues does not change 
the stability of fibril where in each chain the residues 11-42 stay in their triple-β-strand motif, see 




Figure 3.2. Aβ1-42 (a) initial conformation. (b) representative conformation after 200ns. 
 
We remark that we have also simulated the five-chain fragment with a different force field,  
CHARMM27165, to exclude the possibility of artifacts introduce by choice of a specific force field 
(Amber ff99sb-ilde151) Final configurations, and the evolution of secondary structure and root-
mean-square deviation along the trajectories are  similar for both force–fields (data not shown) 
suggesting that  our results are not biased by the choice of force-field. In order to exclude yet 
another possible source of bias, we have also repeated our simulations taking this time as start 
configuration not the first entry of the NMR ensemble but  the one  that has the largest root-mean-
square deviation to the first entry. This is the ninth model which differs from the first model in the 





simulation similar in terms of stability (data not shown), and we conclude that our results do also 
not rely on the choice of a specific NMR entry. 
 
3.3.2. Temperature Dependence of Fibril Stability  
 
The speed with that fibrils evolve over time is a function of temperature. In general, fibrils will 
dissolve faster at elevated temperature. Hence, in order to assess the stability of our fibril fragments 
in another way we have  simulated the five-chain-fragment at elevated temperatures 330K, 350K, 
375K and 400K. We display in Fig. 3.3 the root-mean-square fluctuation (RMSF) of the chain 
residues as function of temperature together with representative configurations sampled at the 
various temperatures. As the temperature rises, the root-mean-square-fluctuations of residues 12-
18 in the β1 strand grow far more than the corresponding values of residues in the β2/β3 regions. 
This indicates a higher flexibility of the β1 strand compared to the more rigid β2-turn-β3 motif  of 
residues 24-40. The difference in stability persist up to 375K, and only at 400 K have both the 
β1(12-18) and β3(36-40) lost their initial conformation. The root-mean-square-fluctuations of the 
residue 17-20 (forming a turn), and of the residues 30-42 of  the β2-strand  are lower than that of 
the other segments, indicating the higher stability of these parts. The residues K16 to E22 are 
known to form the hydrophobic core of Aβ peptides.166 In  the triple-β-motif, the phenylalanine 
residues at position 19 and 20 have their side chains engulfed by the turn 1 region. This is different 
from the previous models of Aβ1-42129 where  the residue F19 is exposed to solvent. In the β2 
region,  the hydrophobic residues I31 and I32 are also packed inside the turn region instead of 
being  exposed to solvent. The side chain of residue I31 points to the  turn 2 region while the 





because of this packing of hydrophobic residues it appears that the turn 1 and β2 region in the new 
model are energetically more favorable  than they are in the previous models of Aβ1-42].  
 
 
Figure 3.3. (a) Variation of the residue-specific RMSF with temperature averaged over all five 
chains of the fibril.  Shown are also representative conformations of the chains at temperatures 330 







3.3.3. Role of the K28-A42 Salt-bridge 
 
The previous model of Aβ1-42 has a  salt bridge  between residues D23-K28129 that is also found in 
Aβ1-40130 fibrils with  two-fold-symmetry, and that is known to be important for the stability of 
these fibrils.167 Note, however, that no salt-bridge is formed by residue K28 in Aβ1-40 fibrils with 
three-fold-symmetry. In the new model, the side chain of K28 form an intra-chain salt-bridge with 
the main chain of the  C-terminal residue A1-42.146  Xiao et al have speculated that the stability of 
the newly found structure depends on formation of this salt bridge,146 and that the impossibility to 
form this salt bridge in Aβ1-40 peptides is the reason why the  triple-β-strand motif  is not seen in 
Aβ1-40 fibrils. In order to test this hypothesis, we have compared simulations of the wild type Aβ1-
42 with that of mutants K28A. However, while the C-terminal segment became more flexible and 
the β-strand propensity in the β3 region  decreased, see Fig. 3.4a and c, did the β2-turn-β3 motif 
in the mutant not dissolve over 200 ns of simulation. The stability of this motif suggests  that, 






Figure 3.4. Representative conformation of mutation K28A(a) and Aβ11-40(b). (c)The RMSF of 
the K28A  mutant Aβ11-42 (red) and Aβ11-40(yellow) compare to the wild type Aβ11-42 (blue). 
 
One way to test this conjecture is by simulating the fibril with each of the five chains truncated to 
residues 11-40. If this system which also does not have the K28-42 salt bridge has a different 
behavior, it would indicate that not the K28-A42 salt bridge is responsible for the stability of the 
new form but rather other interactions involving the missing two C-terminal residues I41 and A42. 
Indeed we find in simulations of the truncated system the stability of the β2-turn-β3 motif (residues 
24-40) greatly reduced. (Fig. 3.4b). Without the last two residues, the β3 strand (residues 36-40) 
becomes too short to form a β-strand and the chains rather assume an  U-shape form similar to the 
one  seen for Aβ1-40 in previous ss-NMR experiments.129, 130 The C-terminal residues 35-40 turn 





the solvent. Besides excluding the possibility to form the K28-A42 salt bridge, the lack of the 
terminal two residues I41 and A42 also removes the hydrophobic contacts of residues I31-I41 and 
residues V39-I41. The side chains of residues I31 and V39 are now exposed to solvent and the 
three hydrophobic residues I31, M35 and V39 can no longer  maintain the β1-turn-β2 motif. On 
the other hand, the root-mean-square-fluctuations  of the β1-turn-β2 motif (residues 12-33) did  not 
change in the truncated version (Fig 3.4c), i.e. the β2-strand is still preserved.  Hence, comparing 
the truncated system with the mutant system, which both lack the salt-bridge K28-A42, it  appears 
that the stability of the newly found Aβ1-42 fibril structure depends more on the contacts and steric 
constraints induced by the C-terminal residues I41 and A42 than on the salt bridge K28-A42.  
 
While our above result suggest that the salt bridge K28-A42 is not the leading factor in the stability 
of the new motif seen in Aβ1-42 fibrils, formation of the salt bridge may be a key factor in the kinetic 
process that leads to folding of the triple β-strand structure. In order to see whether the salt-bridge 
is a guiding factor, we have further simulated wild type systems that started from configurations 
in which  the β2-β3 sheet is  broken,  but where the K28-A42 salt-bridge is preserved. If this salt 
bridge guides the formation of the new motif one would expect that this motif (i.e.  the β3-strand 
and its attachment to the β2 strand)  would re-form over the course of our simulation.  The initial 
conformation is derived from high-temperature simulations with the  K28-A42 salt-bridge and 
residues 11-28 restrained, and is shown in supplemental Fig. S3.5a. As for the other systems, we 
follow our system in four independent trajectories. In none of these runs does  the  β3 strand re-
form. Instead, we observe a gradual disruption of the amyloid conformation as shown in Fig. 3.5b. 
During the 200 ns of simulation time, the K28-A42 salt bridge remains stable, but the residues 29-





the C-terminal β-sheet raises further doubts on the importance of the K28-A42 salt-bridge for 
forming and stabilizing the new structure. However, we cannot exclude the possibility that the  β 
sheet would need longer than the 200 ns of our simulation time to form again. Previous 
experiments and molecular dynamics simulations indicate that  a strand-loop-strand motif requires 
microsecond to milliseconds to form, 168 much longer than our simulations, albeit we would expect 
a faster process for our system as the K28-A42 salt bridge restricts the conformation space.   
 
 
Figure 3.5. Aβ11-42 fibril with the β2-β3 strand broken but intact K28-A42 salt-bridge. (a) initial 
states. (b) representative final conformation with disrupted  β2-turn-β3 motif but most of the K28-
A42 salt-bridge is still preserved. 
 
 
3.3.4. Packing Surfaces of Aβ1-42 Fibrils with Two-fold-packing Symmetry 
 
While it was initially assumed that the Aβ1-42 fibril existed as single-fold conformation129 build out 
of a single protofibrils, later ss-NMR experiments have shown that the Aβ1-40 fibril can exhibit  
two-fold130 or three-fold packing symmetry131, 132, with, for instance, in the two-fold arrangement 





salt-bridge formed between D23 and K28.130 In the three-fold arrangement there is no  D23-K28 
salt-bridge  and the packing surfaces are made out by  segments of residues 28-31 and the C-
terminal of the chains.131 In the patient brain-derived fibril the chains also arrange with three-fold 
symmetry,  packing through residues 22-31 and the C-terminal.132 In all the above cases,  the Aβ 
chains take the previously known U-shape form. Whether the recently found triple-β-stranded form 
is part of fibrils with a single fold, or such with two-fold or three-fold symmetry, is  yet not resolved 
experimentally. In order to explore the possibility of fibrils with two-fold packing symmetry, made 
out of chains with the triple-β-strand motif, we have constructed various arrangements that differ 
in their packing surface, and have investigated their stability. The single chain has two strands that 
can be exposed to the solvent, the  β1-strand and the β3-strand. Hence, one can expect that the two 
chains in each unit will associate through the surfaces formed by these strands. This suggests the 
two arrangements shown in Fig. 3.6. Fig. 3.6a displays  the case where the two chains assemble 
by way of their β1-strands in such a way that the charged residues K17, E22, and D23  form inter-
chain salt-bridges. Fig. 3.6b presents another possible arrangement where the two chains assemble 
by way of much shorter (five-residue long) β3-strands. Here, the two chains are arranged in such 
a way that the number of contacts  involving the hydrophobic residues G38-V40 is maximized.  
We call the arrangement in Fig 3.6a where the two chains assemble by way of their  β1-strands  








Figure 3.6. The initial states of two proposed chain arrangements in fibrils with two-fold symmetry 
(a) PSA, packing between β1 -  β1. (b) PSB, packing between β3-β3.  
 
Even after 200 ns of simulation time did neither the PSA no the PSB fibrils separate. 
Representative conformations are shown in Fig 3.7. In the PSA fibril does the residue K16 form 
an inter-chain salt bridge with residues  E22 or D23 that stabilizes the two-fold (Fig. 3.7a). The 
residues segment 16-23  bent so that a water pore is formed between the  surfaces in contact. Since 
the β1 strands are twisted, the whole fibril has a twist. On the other hand, the chains in the PSB 
fibril interact mainly through contacts between the side chains of residue V40 (Fig. 3.7b). The β2-
turn-β3 motif stays stable in both chains, and as the β3-strand does not develop a twist, the whole 







Figure 3.7. Representative conformations of fibrils with two-fold symmetry. (a) In the PSA 
arrangement, residue K16 forms an inter-chain salt bridge with residues E22/D23. The cross-
section of the fibril is about 6.6x5.1 nm2. (b) the PSB arrangement is stabilize by contacts between 
the residues V40,  and the cross-section is about 7.8x3.9 nm2.  
 
We show the time evolution of the root-mean-square-deviation of each chain shown for both the 
PSA and PSB fibrils is in Fig. 3.8. The values for both arrangements are with about 0.7nm  
comparable with the values measured for the  single-fold fibrils shown  in Fig 3.1b  In agreement 
with the above discussed visual inspection of the final states these values indicate that on the time 
scale of our simulations (200ns) fibrils with two-fold packing symmetry are stable. However, the 
PSA and PSB arrangements differ in the diameter of the resulting fibrils. For the PSA fibril we 
find a cross-section of  6.6x5.1 nm2, and a corresponding value of  7.8x3.9 nm2 for the PSB fibril. 
Hence, fibrils with a PSB arrangement of chains are more oblate than such within a PSA 
arrangement of  chains. Transmission electron microscopy measurements lead  to experimental 
values for the fibril diameters  in the range of 4.5-6.0 nm for thinner filaments, and 6.0-14.0 nm 





filaments cannot be formed by single-fold fibrils, and both the PSA and PSB arrangements are in 
better agreement with the experimentally measured diameters.  
 
Figure 3.8. Root-mean-square-deviation of each layer in fibrils with two-fold packing -symmetry. 
 
We have further analyzed the two chain arrangements in fibrils with two-fold symmetry by 
estimating the binding energy of the two chains within the  MM-GBSA approximation. In fibrils 
with PSA arrangement of chains we find as total binding energy -56.3±1.2 kcal/mol and a slightly 
higher value of -46.6±0.5 kcal/mol for fibrils with  PSB arrangement of chains. The various terms 
that make up the binding energy are listed in Table 3.1. The contributions of each residue to the 
binding energy are shown in Fig. 3.9a.  The two chain arrangements are shown again  Fig. 3.9b 
and 3.9c,  but now with the residues colored according to their binding energy contribution, with 
red marking attractive interaction and blue repulsive terms. In PSA fibrils the strongest 
contribution come from interactions involving residues K16 and E22 or D23, i.e. the residues  that 
form the inter-chain salt bridge. This observation is consistent with the large contributions from 
electrostatic and  solvent term for this fibril arrangement, see Table 3.1. Similarly, the most 





correspondingly, the binding energy estimate is dominated by the VDW interactions and solvation 
energy.  While the absolute values indicate a slighter preference for a PSA arrangement of chains,  
these numbers have to be taken with a grain of salt as conformational entropy contributions are 
not accounted for in our MM-GBSA analysis.  However, the calculated binding energy estimates 
support our earlier observation that both chain arrangement will lead to stable fibrils. As the 
diameters of such fibrils with two-fold packing symmetry  is in better agreement with the 
Transmission Electron Microscopy measurements than that of single-fold fibrils, we believe that  
Aβ1-42 chains with triple-β-strand structure  likely build fibrils with two-fold packing  of the chains. 
Both the PSA and the PSB arrangements appear to be valid candidates. While the PSB fibril model 
is in better agreement with the experimentally measured fibril diameters, the PSA model leads to 
a lower MM-GBSA binding estimate. As the chains in this arrangement are hold together by 
contacts involving the charged residues K17, E22 and D23 between the two chains, a PSA 
arrangement in fibrils with two-fold packing symmetry may also explain why the in other fibril 
















Table 3.1. Binding energy of fibrils with either PSA or PSB arrangement 
 Binding energy 
Kcal/mol  with Std. Err. 
 PSA PSB 
Evdw -12.7 (0.9) -73.1 (0.6) 
Eelect -1800 (30) 173(3) 
EGB 1764 (29) -139 (3) 
Esurf -8.5 (0.2) -7.9 (0.1) 








Figure 3.9. Binding energy between protofibrils in fibrils with two-fold packing. (a) Binding 
energy distributions for  each residues. The coloring  for corresponding residues in β1(b) and β3(c) 









Using molecular dynamics simulations we have studied the stability of a recently resolved high-
resolution   structure  for wild type homogenous Aβ1-42 fibrils146 that differs significantly from 
previously found Aβ1-40 fibril130-132 and low-resolution Aβ1-42 fibril structures129: the individual 
chains form a triple-β-strand motif instead of a U-shape.  It is tempting to assume that the 
difference in structure is correlated with the higher neurotoxicity of  Aβ1-42 amyloids but the 
relevance of the new motif is not clear. We find a critical fibril size of five to six chains. Fibril 
fragments with less than five chains dissolve while such with six or more chains change little  over 
the course of our simulations. Hence, the critical size  is larger for the newly found  Aβ1-42 fibrils  
than  for the earlier found low-resolution Aβ1-42 fibril structures161 where it is three to four chains. 
This larger critical size may indicate a higher free energy barrier for forming the Aβ1-42 fibrils  with 
the triple-β-strand motif than for forming  Aβ1-42 fibrils  with U-shaped chains.  This could explain 
why this motif has not been observed earlier and would also suggest a longer nucleation phase for 
such fibrils. On the other hand, the new structure is surprisingly stable for temperatures up to 400 
K.  At a physiological temperature of 310 K all three β-strands persist during molecular dynamics 
simulations of up to 500 ns, with  the β2-turn-β3 motif   more stable than the β1 strand. Unlike the 
β1-strand the strands in this β2-turn-β3 motif surprisingly do not become twisted even after 500ns. 
The lack of an energetically more favorable twist in the middle and C-terminal strand suggest 
strong packing interactions that were missing in previous molecular dynamics simulations of other 
Aβ-fibril models  where initially untwisted strands always quickly became twisted. These strong 
packing interactions suggest that Aβ1-42 fibril with the triple-β-strand motif  are energetically more 
favorable than  the previously found low-resolution Aβ1-42 fibril models with U-shaped chains. One 





aggregates.  Simulating the mutant K28A and wild type systems where the residues I41 and A42 
are truncated, we find that the salt bridge between the side chain of K28 and C-terminal of A42 
adds to the stability of the structure, but  appears to be neither for kinetic nor thermodynamics 
reasons necessary for its formation and stability. Instead, the  stability of the β2-turn-β3 motif 
depends on  the hydrophobic packing of side chains and steric constraints induced by the C-
terminal residues I41 and A42. This explains why Aβ1-42 fibril with  the triple-β-strand motif  can 
seed fibril growth of  Aβ1-42  chains but not of  Aβ1-40  chains, and we  expect that mutations of these 
two C-terminal residues will disrupt the triple-β-strand motif, i.e that these mutants could not be 
seeded by wild type Aβ1-42 fibril with  the triple-β-strand motif.  Such mutation studies may also 
help to identify the mechanisms that separate formation of  wild type Aβ1-42 fibril with  the triple-
β-strand motif  from such with U-shaped chains. In order to study this question we are now also 
preparing simulations that will probe transitions between these two states. We have finally 
considered different packing arrangements of protofibrils build out of Aβ chains with the triple-
strand motif. In these fibril models, two chains either interact by contacts between residues in their 
β1 strands, or by residues in their   β3 strands. Approximating the binding energies between the 
two protofibrils by MM-GBSA estimates, we find that both arrangements are more favorable than 
single fold fibrils, but our analysis does not allow us to select one of the two arrangements as the 
more likely one. As the geometries of both of our proposed arrangements are more consistent with 
Transmission Electron Microscopy measurements than single-fold fibrils146, we conclude that both  
arrangements are valid candidates for fibrils with two-fold packing symmetry. This conjecture 
could be tested by mutation experiments involving the residues K16, E22, E23 that are not critical 
for the stability of fibril but for the packing chains. We would expect that such mutations lead to 





fibril packing with three-fold or higher fold organization. While the PSB arrangement cannot be 
extended to a three-fold model, this would be possible for a PSA like packing involving residues 
K16 to E22 or D23.  Packing through contacts involving these residues  allows for formation of 
an equilateral triangle leading to fibrils with a diameter of approximately 11 nm, also consistent 
with the values of 6.0 nm to 14.0 nm measured for thicker filaments by Transmission Electron 
Microscopy. 
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Chapter 4. Stability of the N-terminal Helix and its Role in Amyloid 




The material in chapter 4 is adapted from Wang, W., Xi, W., & Hansmann, U. H. (2018). Stability 
of the N-Terminal Helix and Its Role in Amyloid Formation of Serum Amyloid A. ACS 
omega, 3(11), 16184-16190. Open access journal and no copyright is required.  
Author Contributions:  This work in this chapter is majorly credited to Wenhua Wang,  Dr. 





A large spectrum of diseases is connected with the presence of amyloid fibrils that after staining 
with Congo Red are visible under ultraviolet light. Depending on the specific disease, these 
deposits are either systemic or localized (for instance, in the patient’s brain in the case of 
Alzheimer’s disease), and appear either spontaneous or as the consequence or byproduct of another 
disease.169-173 An example for the latter, so-called   secondary, amyloidosis  is Colonic Amyloidosis 
where in response to inflammation  the precursor protein Serum Amyloid A (SAA) is 
overexpressed.  174 Normally, SAA is found with a concentration of 1-3 μg/ml in human blood,  
but in patients with colon cancer  or inflammatory bowel disease the concentration of SAA  can 
approach more than 1 mg/ml. This extremely high concentration then encourages mis-folding and 
aggregation of SAA, leading to the  outbreak of colonic amyloidosis as a secondary disease that 





Serum Amyloid A is built out of   104 amino acids, however, in extracellular environment, or in 
amyloids, one does not find the complete protein but rather the truncated fragment SAA(1-76).     
The structure of the full-size protein has been  resolved by X-Ray crystallography22  and deposited 
in the Protein Data Bank (PDB) under identifier 4IP8. While the crystal structure, shown in Figure 
4.1, is for   a hexamer, it is stable  for the monomer, and characterized by a long C-terminal tail 
that wraps  four helices corresponding to residues 1-27, 32–47, 50–69 and 73–88.22 From mutation 
experiments it is known that  the first eleven residue  are crucial for the  mis-folding and 
aggregation of SAA in colonic amyloidosis  as their lack  prevents the aggregation of SAA.23 In 
the crystal structure, these residues are part of the N-terminal α-helix, but it was proposed by 
Nordling and Nordling24 that residues 1-13 can mis-fold into a β- hairpin structure whose presence 
will trigger aggregation. 
 
This idea is consistent with Jannone’s observation of Raman spectra  seen during  SAA(1-12) 
aggregation25, and our own simulations which  show an equilibrium between α-helix to β- hairpin 








Figure 4.1. The crystal structure (PDB ID: 4IP8) of the full-size SAA monomer. The purple 
segment is helix I (residues 1-27). Helix II, III, and IV and the C-terminal tail, consisting of 
residues 28-104, are drawn in yellow. Labels mark the N- and C-terminals. 
 
A drawback of our previous study is that it considered only an isolated segment formed by residues 
1-13. However, in the crystal structure these residues part of an α-helix spanning from residue 1-
27. The local environment formed by this α-helix will likely alter the landscape of the 1-13 segment 
and the mechanism of the helix-hairpin transition. For this reason, we extend here our previous 
study to the segment formed by the first 27 residues of SAA, investigating structural transitions in 
it,  and the potential role of these transitions in the formation of SAA amyloids. For this purpose, 
we consider not only the wild type, but probe also how landscape and transition mechanism are 
altered by the mutation of residue 9 from a Glutamic Acid into an Alanine (E9A), a mutation that 
disrupts a potentially helix-stabilizing salt bridge seen in the wild type at neutral pH.  Our results 
rely on large-scale simulations using a variant replica exchange molecular dynamics (REMD), 
multi-exchange replica exchange molecular dynamics (ME-REMD), which raises the efficiency 
of regular REMD by attempting multiple exchanges of neighboring replicas between the molecular 





in efficiency by this approach.  




The initial configuration is derived from the corresponding fragment (residue 1-27) of the crystal 
structures of full-length serum amyloid A protein 1.1 (PDB ID: 4IP8). The mutation-type SAA (1-
27) E9A were built from the wild-type by replacing the negatively charged side chain of Glutamic 
acid with the hydrogen atom of the alanine side chain. The so-obtained configurations of wild-type 
and mutant are together with 4700 water molecules placed in a box with box size 5.4 nm and 
periodic boundary conditions, and melted by molecular dynamics simulation at 500 K to  generate 
random configurations as starting point for the molecular dynamics simulations in this study. 
4.2.2. Simulation Protocols  
These simulations are done with the GROMACS 4.5.6 software package.178  The CHARMM 27 
force field with CMAP and TIP3P water model 152, 179CHARMM TIP3P are employed in replica 
exchange molecular exchange (REMD) and multi-exchange replica-exchange molecular dynamics 
(ME-REMD) of the SSA(1-27) fragment in the isothermal-isobaric (NPT) ensemble.178 Each 
replica is followed over 300ns. For REMD, the system contains 36 replicas, spread between 300 
K and 420K, for ME_REMD only 28 replica are distributed over this temperature interval. The 
temperatures are controlled by  velocity rescaling2,180 and the pressure is kept at 1 bar  by the 
isotropic Parrinello-Rahman’s method. Constraining peptide bonds with  LINCS153 allows us to 
integrate the equations of motions   with a time step of 2 fs.   Replica  exchange are attempted  





keep a constant pressure at 1 bar. Because we use periodic boundary conditions are long-range 
electrostatic interactions calculated  with Particle Mesh Ewald 181 algorithm using a 1 nm cutoff. 
The same   cutoff is employed for calculation of van der Waals interactions. 
For the data analysis we omit the first 200 ns to allow the system to reach equilibrium. Only the 
310 K replica is considered in REMD simulations, and the 308 K replica in ME-REMD 
simulations. The secondary structure of configurations is calculated with the   PROSS algorithm182 
which relies on measurements of dihedral angles only.  Configurations were cluster with an in 
house tool defining clusters by certain geometric motifs (such as extended helices, helix-hairpin) 
of the configurations. Sidechain contact maps were derived using the gromacs tool g_mdmat which 
is based on the mean distance between each residue. The solvent accessible surface area analysis 
is conducted by using gromacs tool g_sas. 
4.3. Results and Discussion 
 
 
4.3.1. System Set-up 
In the present study we use molecular dynamics simulations to investigate structural transitions in 
the N-terminal segment SAA (1-27), a protein implicated in colonic amyloidosis. In order to ensure 
validity of our results we have to make certain that the set-up of our simulation does not introduce 
a bias to our data. Such bias could come, for instance, from a too small simulation box that would 
cage the molecule and therefore restrict its configurational space. In supplemental Figure S4.1 we 
present results from short constant temperature (400 K) simulations of the wild type fragment SAA 
(1-27) for cubic boxes of length 4.8 nm, 5.4 nm, and 5.6 nm.  Shown is the probability of a residue 





5.4 nm and 5.6 nm are consistent, but differ from that of box size 4.8 nm. Hence, we conclude that 
a box size of at least 5.4 nm is necessary in simulations to minimize the finite size effects.  
In a similar way, we need to make sure that the temperature distribution allows a walk of replicas 
through temperature space, and that the highest temperature is sufficiently large to enable crossing 
of all relevant barriers in the system. The lowest temperature is given by our target temperature, 
T=300 K. Short constant temperature runs indicate that a temperature of T=420 K is sufficient to 
dissolve the helix, and for this reason we choose T=420 K as our maximal temperature. The 
distribution of temperatures between the two extremes can be determined for a given number of 
replicas by the algorithm of van der Spoel.183 Especially, we find that 36 replicas lead to an average 
acceptance probability of 18% which we consider acceptable. Simulating the wild type with this 
box size and temperature distribution for 300ns, and evaluating various quantities, such as the 
secondary structure probability of certain segments, for different time intervals, we find that a 
regular REMD simulation converges within 200 ns. Hence, this set-up for regular REMD (see 
supplemental Figure S4.2) is used as our standard against which we compare all considered 
variants when testing the efficiency of multi-exchange replica-exchange molecular dynamics (ME-
REMD). 
4.3.2. Comparing the Efficiency of REMD and ME-REMD Sampling 
Replica exchange molecular dynamics (REMD) is a method to enhance sampling of configurations 
in systems where large barriers in the energy landscape lead to slow sampling.   REMD alleviates 
this problem by introducing a walk through temperature space. At high temperature, barriers can 
be easily crossed, while at low temperatures more relevant low-energy configurations are explored. 





size (or otherwise the acceptance for exchange moves becomes vanishingly small). This makes 
simulations of proteins in explicit water (i.e., where the system consists of the protein and a much 
larger number of water molecules) cumbersome. One way to raise the effective transition rate is 
to attempt multiple exchanges for two neighboring replicas.184 As a consequence, a given replica 
can cover a large range of  temperatures between two molecular dynamics segments if a series of 
exchange attempts between  pairs of neighboring replicas are made, resulting in a faster walk in 
temperature space.  While it appears reasonable to assume that such an approach will lead to 
improved sampling, it is important to explore systematically the gain in efficiency that can be 
obtained, and how this gain depends on the number of such exchange attempts within one exchange 
cycle.   
Hence, in a first step we took our system of 36 replicas, simulated with regular REMD, and we 
varied the number of exchange attempts from N=1 to N=5, 10, 20 and N=100. The resulting 
effective exchange rates for the various temperature pairs are shown in Figure 2a, and suggest a 
fast approach to an optimum, with increasing the number of attempts beyond N=10 not raising the 
effective exchange rate noticeable. Here, we define the effective exchange rate by the number of 
times that, after the series of N exchanges, the final and initial configurations of a replica differ.  
As a consequence of the higher exchange rate, replicas walk faster in temperature space. This can 
be seen in table 1 where we list the number of tunneling events and average tunneling times for 
various N. Here, we define a tunneling events as the walk of a replica through the temperature 
space, from lowest temperature to highest temperature and back, see Figure 4.2c and 4.2d for 
illustration. Note in table 1 the much faster walk in temperature space with ME-REMD than seen 





One possible application of the increased effective exchange rates and faster walk in temperature 
space, is the possibility to use ME-REMD with a smaller number of replicas than needed for 
regular REMD. Varying the number of replicas in the same temperature interval of T=300 K to 
T=420 K from M=36 to M=28 we measured again for various numbers N of exchange attempts 
the resulting effective exchange rates, and plot these in Figure 4.2b. As in the case of M=36 
replicas, the effective exchange rate approaches an optimum for N » 10. For M=28 replicas 
corresponds this optimal effective exchange rate to the one seen when the original system (M=36) 
is simulated with regular REMD. In a similar way agree the number of tunneling events and 
average tunneling times, see table 1. For illustration, we show in Figure 4.2c and 4.2d for both the 
36 REMD and the 28 ME-REMD simulations example walks of replicas through temperature 
space. Hence, by using ME-REMD instead of regular REMD we reduce the number of replicas in 








Figure 4.2. a) Observed exchange rate in simulations of the SAA (1-27) fragment, the red line is 
the exchange rate for 36 replica REMD, orange, blue, black and purple lines stand for the 
accumulated exchange rate  in ME-REMD with N=5,10,20,and 100. B) Similar to a), the orange, 
blue, black and purple lines stand for the accumulated exchange rate in ME-REMD with 
N=5,10,20, and 100, but now for a simulation with only 28 replicas distributed over the same 
temperature interval of 200K to 420 K; for comparison is also shown the regular REMD simulation 
of the 36 replica system.  
 
Various approaches have been proposed in the past that result into faster walks through 
temperature space. In some cases, these approaches lead to biased sampling and non-reliable 
results. In order to exclude this possibility, we compare in Figure 4.3 the secondary structure 
propensity of the residues as measured with regular REMD for our original system of M=36 
replicas, with the data measured in our ME-REMD simulation of the system with M=28 replicas. 
In both cases, we find a propensity for formation of  α-helices of about 50%,  51 % for ME-REMD 





middle panel of Figure 4.3. In both REMD and ME-REMD results, we observed that the wild type 
SAA(1-27) fragment has a tendency for the  helix to break around residue 11-13. The qualitative 
and quantitative  similarity between the two runs shows that the enhanced sampling in ME-REMD 
does not introduces any biases into our simulation; and for our further analysis we therefore rely 
on the data obtained with ME-REMD sampling. 
Table 4.1. Number of tunneling events, average tunneling time and average exchange rate over 











36 Replicas REMD 
WT 
0-300 46(1) 47.7(3.8) 17.9(0.2) 
28 Replicas ME-
REMD WT 
0-300 40(5) 54.6(7.1) 14.7(0.1) 
28 Replicas ME-
REMD Mutation E9A 
0-300 30(3) 59.4(4.1) 11.3(0.1) 
 
4.3.3. Configurational Ensemble of SAA (1-27) Monomers 
 
While in the crystal structure of Ref. 11 all 27 residues form an α-helix, the helix propensity is 
reduced in our simulations, with a break of the helix around residues 11-13. These results are 





prevent aggregation.  Our data indicate three regions: helix Ia (residue 1-11), turn (residue 12-13), 
helix Ib (residue 14-27).  As the first segment, residues 1-11, has a lower helicity than the segment 
formed by residues 14-27, it follows that the helix Ia is less stable than helix Ib, and its presence 
or lack of therefore may well be the key for aggregation to happen.   
The secondary structure propensity distribution is consistent with our clustering analysis where we 
group configurations according to the secondary structure propensity of residues 1-11 and 14-21 
(residues 22-27 are always helical and therefore ignored for clustering). We find three main 
clusters. The first cluster is made of configurations with a helix-turn-helix hairpin, with at least 
five consecutive residues in each of the two segments identified as helical, but separated by at least 
two residues that are not helical. The second cluster is made of configurations with a stable helix 
Ib (again defined by the requirement of at least five helical residues in the segment 14-21), but 
where the N-terminal residues 1-11 form an elongated, disordered and dynamically changing 
segment (with no more than three consecutive helical residues). Finally, the configurations in the 
third cluster are characterized by single long helices, resembling the crystal structure for this 
fragment, and are defined by the requirement of a single helix of at least 14 residues covering both 
segments. Example configurations are shown in the upper level of the left and middle panel of 
Figure 4.3. The helix-turn-helix cluster has the largest population and is contains about 33% of all 
configurations. The second largest group is the disordered N-terminal cluster consisting of about 
25% of configurations. The lowest frequency (5%) is seen for configurations with the native-
structure-like single extended helix. The various frequencies are listed in Table 2. 
The above results raise the question on what breaks the extended helix seen in the crystal structure, 





the role of the first eleven residues in amyloid formation of SAA? Residue 13 is a glycine and 
residue 14 an alanine, and both residues make it likely to break the helix in this segment. Residue 
11 is a phenylalanine whose aromatic sidechain may form a weak hydrophobic contact with 
residue 21Y to break the extended helix motif and stabilize the helix-turn-helix motif, shown in 
Figure 4.5B.  Residue 12 is an aspartic acid, and Figure 4.5 A and B indicate that there is weak 
contact between residue 1R and residue 12D sidechain in the extended helix motif that is not 
observed in the helix-turn-helix motif.  Hence, the two residues may form a transient salt bridge 
which stabilizes the extended helix motif, while on the contrary the helix-turn-helix motif is 
preferred when the  salt bridge dissolves.   Hence, while helix 1 (residues 1-27) is stable in the 
crystal structure of the full protein as a hexamer, the higher flexibility of the much smaller segment 
SAA(1-27) allows  this helix to break up around residues 12 and 13 into two segments, the N-
terminal helix Ia (residues 1-11) and Ib (residues 14-27).  
 
Figure 4.3. Secondary structure frequency (lower row) and representative configurations for the 
dominant motifs (upper row) as found in REMD simulations with 36 replica of the wild type SAA 
(1-27) fragment (left panel), in ME-REMD simulations with 28 replicas  of the wild type SAA(1-
27) fragment (middle panel), and in ME-REMD simulations with 28 replicas  of the E9A mutant 
SAA(1-27) fragment (right panel).  The frequency of α-helices is drawn in black, that of turns in 
blue, and of β-strands in red. The same color coding is used in the figures in the upper panel, with 






In order to understand the appearance of the helix-hairpin motif we calculate the contributions of 
each residue to the solvent accessible surface area (SASA) and compare the obtained values for 
the different motifs. The corresponding values are shown in Figure 4.4. In helix-hairpin 
configurations, the hydrophobic residues 3F, 21Y and 24 are less exposed to water than in the 
straight helix of the crystal structure. Hence, we conclude that the helix hairpin is stabilized by 
hydrophobic contacts involving these residues as shown in Figure 4.5B, that do not exist in the 
elongated helix of the crystal structure (see Figure 4.5A).  
 
Figure 4.4. Solvent accessible surface area (SASA) of each residue as measured in our ME-REMD 
simulations when the SAA (1-27) fragment is in either a helix-turn-helix configuration (red) or in 
the elongated helix also seen in the PDB structure (blue).  
 
In earlier work10 we have studied the segment SAA (1-13) which includes the helix Ia forming 
residues. These previous results established a  conformational transition between an α-helix and a 
β hairpin that is associated with the dissolving and forming of salt bridges involving residues 1R, 
5S, 9E, and 12D.  Specifically, by comparing the wild type with suitable mutants we found that 





fragment vanished in the mutant E9A. A corresponding analysis of the contact map of the wild 
type SAA (1-27) in Figure 4.5B also indicates that the N-terminal helix Ia is stabilized in the helix-
turn-helix configuration  by electrostatic interactions between the charged residues 1R and 9E, 
which are within  0.45 nm, and therefore have a  high probability to form a salt bridge. We 
conjecture that the  hydrophobic contacts between the  helices Ia and Ib favor a helix hairpin; 
however, the  propensities of residues 1-11 to form helix Ia are weak, and require an alignment of 
residues enforced by  the salt bridge between residue 1R and 9E. Loss of this salt bridge leads to 
a transition of the  helix-hairpin structure to configurations with helix Ib intact but the N-terminal 
residues forming a dynamically changing disordered elongated segment (see Figure 4.3c) with 
transient   b-strands that is prone to aggregation.  
Table 4.2. Percentage of population of different type of cluster for different systems 
Systems Helix-turn-helix N-terminus dynamic Straight 
Helix 
ME-REMD Wild Type 33 (2) % 25 (9) % 5 (2) % 







Figure 4.5. Sidechain-sidechain contact map as calculated from our ME-REMD simulations of 
the SAA (1-27) fragment. Shown are in A) the results obtained for the case that the wild type 
peptide assumes the extended helix motif seen in the PDB structure. Correspondingly, we show in 
B) this map for the case of the wild type peptide in the helix-turn-helix configuration. Note the 
strong signal for a salt bridge between residues 1R and 9E sidechain and the hydrophobic contacts 
between residues 3F, 21Y and 24M, missing in the PDB structure.  By design is the salt bridge 
between residues 1 and 9 missing in the contact map of the E9A mutant in mutant in a the helix-
turn-helix configuration, shown in  C).  Instead we find here a signal for a salt bridge between 
residue 1R and 26E, and for hydrophobic interaction between residue 3F and 21Y or 24M. 
 
In order to test this hypothesis, we have performed additional ME-REMD simulations of the E9A 
mutant, using the same temperature distribution and number of replicas as for the wild type. 
Acceptance rates and tunneling times are also  listed in table 1. Comparing the mutant with the 
wild type, we find indeed a lower propensity for helix formation in the first 11 residues, and an 
increase of turn formation to 40%, see  the  middle and right panel of figure 4.3. As a consequence, 
we observe only two dominant clusters for the E9A mutant, with the frequency of helix-hairpin 
configurations decreasing to 13 % compared with the 33 % in wild type, and on the contrary, the 
content of aggregation-prone configurations lacking helix Ia growing  to 50 % compared with the 
25 % in wild type, see Table 2. Hence, the replacement of a charged lysine by  an alanine as residue 





configurations. However, the loss of the salt bridge between residues 1 and 9 does not completely 
destabilizes helix Ia. Instead this helix is still weakly stabilized by a salt bridge between the first 
residue 1R and residue 26E, and a larger number of hydrophobic contacts between residue 3F and 
21Y or 24M, that together restrict fluctuations of helix hairpin configurations. These contacts can 
be seen in Figure 4.6C, and also the solvent accessible surface area(SASA) contributions of 
residues 3F,21Y and 24M. Specifically, the residue 3F has in the E9A mutant  about 0.3 Å2   less 
surface exposed to solvent than in the  wild type. The difference is with about 0.2 Å2 similar for 
residues 21Yand 24M.   
4.4. Conclusions 
 
In this study, we have used a variant of the replica exchange molecular dynamic, multi-exchange 
replica exchange molecular dynamic (ME-REMD) to investigate the conformational ensemble of 
the isolated N-terminal segment (1-27)  of serum amyloid A, In the folded structure these residues 
form a single extended helix, but especially residues 1-11 are implicated in the amyloid formation 
of the overexpressed protein. Our first result is that ME-REMD is robust and depends little on the 
number of exchange attempts; i.e. the improved sampling efficiency   is not bought by the need to 
adjust an additional parameter. The rather trivial modification of REMD leads to immediate gains 
of about 20% in sampling efficiency or reduction of required computational resources.  
While a noteworthy result, our main interest is in the dynamics of the long helix formed by residue 
1 to 27 in the crystal structure. This helix is not stable in our simulations of the isolated fragment 
SAA (1-27). Instead, the helix breaks up around residues 12 and 13 in a more than 50% of 
configurations. The resulting helix-hairpin is hold together by hydrophobic contacts between helix 





is  only weakly hold together by a salt bridge between residues 1R and 9E. Hence, in about 25% 
of configurations this helix Ia dissolves and the residues 1-11 form a dynamically changing 
elongated segment, with transient b-strand content that in a more dense environment would  
become the starting point for aggregation. Mutation of residue 9 from a glutamic acid to an alanine 
destroys the salt bridge, shifting the equilibrium away from the helix-hairpin toward a motif with 
increased  b-strand content as also seen in our earlier simulations of the short fragment SAA(1-
13).  
We conjecture that a similar mechanism also applies for the full-length protein. While here  the N-
terminal helix I is likely stabilized by residues 28-76, we expect that it  also exist in a dynamical 
equilibrium with an unstable helix-hairpin configuration where the first eleven residues may form   
transient b-strands that become the nucleus for the aggregation observed in vivo for overexpressed 
SAA. This scenario is  supported by experimental observations showing  a reduction of helicity at 
pH=2 21, and an increase in fibril formation when the SAA(1-27) segment  binds with  acidic 
lysophospholiqids instead of  neutral lysophospholiqids. 185 Since the wild type SAA(1-11) 
fragment has an isoelectric point of 6.0, while that of the E9A mutant is 9.8 (as calculated by the  
ExPASy Server186-188), the loss of charge at residue 9  due to the mutation E9A is similar to going  
in the wild type from neutral pH to acidic conditions. Hence, the experimental measurements are 
consistent with the mechanism that we have derived from molecular dynamics studies of a wild 
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Chapter 5. Cleavage, Downregulation, and Aggregation of Serum Amyloid A 
 
The material in chapter 5 is adapted from Wang, W., Khatua, P., & Hansmann, U. H. (2020). 
Cleavage, Downregulation, and Aggregation of Serum Amyloid A. The Journal of Physical 
Chemistry B, 124(6), 1009-1019. The copyright permission is obtained from ACS, see details in 
Appendix IV.  




In order to function properly, a protein has to take a specific structure either by itself or in complex 
with other molecules. Misfolded proteins lose their function and are usually degraded in cells by 
proteolytic cleavage. 189  In general, much longer time scales are required for a competing process 
by which unfolded or misfolded proteins aggregate instead into assemblies characterized by a 
cross-beta structure termed as “amyloid”. While these amyloids sometimes have specific functions 
in organisms (for instance as storage of hormones190 or as a matrix in bacterial biofilms191), their 
presence in humans and other mammals is more often the hallmark of neurodegenerative, 
metabolic, and other diseases.169, 192, 193 
These amyloid diseases are in some cases secondary illnesses. For instance, the 104-residue long 
serum amyloid A (SAA) protein plays a role in the transport of cholesterol in high-density 
lipoprotein (HDL) particles and is thought to be involved also in a role in the regulation of 
inflammation. In its active form, the protein assembles as a hexamer, built from two layers of 





in the Protein Data Bank (PDBID: 4IP9). The four-helix bundle is shown in Figure 5.1a and 
consists of N-terminal helix-I formed by residues 1−27, helix-II by residues 32−47, helix-III by 
residues 50−69, and the C-terminal helix-IV by residues 73−88. The structure of SAA changes 
little when part of the hexamer (PDB-ID: 4IP8),22  where the chains in each trimer are packed 
together by the N-terminal helices, see Figure 5.1b, and cholesterol binds at the interface between 
the two trimers. Diseases such as colon cancer, inflammatory bowel disease, or rheumatoid arthritis 
can cause overexpression of SAA. The resulting serum concentration of about 1 mg/mL175 is more 
than 1000 times higher than that in healthy persons and gives rise to the outbreak of SAA 
amyloidosis in some patients, which is characterized by the appearance of amyloid deposits, most 
commonly in liver, spleen, and kidney. As the deposits may interfere with the function of the 
affected organs, they add to the symptoms of the primary disease.194 A drastic example is the failure 
of renal function and subsequent death in captive cheetahs caused by amyloid deposits, which 
themselves are because of overexpression of SAA as a consequence of stress-related inflammatory 
diseases.195, 196 
Because SAA amyloidosis is not observed in all patients with the primary disease, it cannot be 
caused solely by crowding resulting from the high concentration. More likely, it is a failure of a 
mechanism to downregulate the HDL transport and other functionalities after the SAA 
overexpression and/or to regulate the immune response to the primary disease.197 However, this 
regulation mechanism is not fully understood. Binding with glycosaminoglycans (GAGs), such as 
heparin/heparan sulfate (HS), leads to dissociation of the hexamer.104, 198 This process should by 
itself foster downregulation of the SAA activity; however, the released 104-residue SAA1−104 
monomers are in a second step and are cleaved into smaller fragments of 45 to 94 residues.199  Most 





fibril model is for the even smaller fragment SAA2−55 (PDB-ID: 6MST).30 It is known from 
mutation experiments that the first eleven N-terminal residues are crucial for SAA misfolding and 
aggregation.23 As part of a hexamer, in the native structure, this segment is cached in helix-I 
(residues 1−27) and stabilized by interactions with the neighboring chains; however, in isolated 
monomers and fragments, it may be flexible enough to form strand-like segments.200 This was 
observed in our lab during molecular dynamics simulations of the fragment SAA1−13, where the 
segment alternated between an α-helix and a β-hairpin.26 Nordling and Abraham-Nordling24  have 
proposed that by taking such strand-like configurations, the N-terminal segment could nucleate 
fibril formation. Given the raised risk for amyloid formation (and subsequent amyloidosis), the 
question arises for what reason the full-length SAA proteins are cleaved into smaller fragments. 
 
 
Figure 5.1. Crystal structure model of the full-sized SAA (SAA1−104) (a) monomer (PDB-ID: 4IP9) 
and the hexamer (PDB-ID: 4IP8) as deposited in the Protein Data Bank. The hexamer is shown 
both in a top-down view (b) and a side view (c). The four helices are colored as follows: helix-I 
(red), helix-II (orange), helix-III (green), and helix-IV (magenta). 
 
In the present chapter, we have explored this question using molecular dynamics simulations of 
the full-length SAA protein and various fragments, both as monomers and assembled into a 





shifting the equilibrium from hexamers toward monomers, thereby reducing the SAA 
concentration. We hypothesize that SAA1−76 is the most commonly found fragment because unlike 
smaller or larger fragments, it allows switching between two distinct structures, enabling a fine-
tuning of the response to the SAA overexpression. Dominant at neutral pH is a structure (coined 
by us helix-weakened) that allows for easy degradation; a process that helps to lower the SAA 
concentration quickly. However, the first eleven N-terminal residues also have an increased risk 
in helix-weakened configurations to unfold from helix-I and to form strand-like segments which 
in turn may nucleate amyloid growth. If acidic conditions raise the risk for aggregation and amyloid 
formation, the equilibrium shifts toward an alternative configuration (termed by us helix-broken), 
where the N-terminus is more stable but is more difficult to degrade. We speculate that, in most 
patients, where colon cancer, inflammatory bowel disease, or rheumatoid arthritis lead to 
overexpression of SAA, the described mechanism downregulates the activity and concentration of 
SAA, but if the switching mechanism is impeded or overwhelmed, an overabundance of the more 
aggregation-prone helix-weakened configurations gives rise to SAA amyloidosis. 
 
5.2. Materials and Methods 
 
 
5.2.1. Initial Conformations  
 
 
For the full-sized SAA protein SAA1−104, we use the crystal structures as start configurations in 
our simulations, derived by X-ray crystallography and deposited in the Protein Data Bank (PDB) 
under identifiers 4IP8 (monomer) and 4IP9 (hexamer). The initial configuration of the fragment 
SAA1−76 monomer is derived by deleting the residues 77−104 from the crystal structure of the full-





crystal structure of the full-length hexamer to construct the start configuration of the truncated 
SAA1−76 hexamer. Each of the two monomer models is placed in the center of a cubic box of edge 
length 6.8 nm and is filled with ∼10,000 water molecules; while for two hexamer systems, the 
cubic box has an edge size of 9.8 nm and is filled with ∼28,000 water molecules. In a similar way, 
we also generate from the SAA monomer two shorter fragments SAA1−27 and SAA1−47 that are put 
again into cubic boxes with edge sizes of 6.2 nm (SAA1−27) and 6.8 nm (SAA1−47), filled with 
∼7800 and ∼10,000 water molecules, respectively. The above obtained configurations are then 
minimized by steepest descent (as implemented in GROMACS201) before simulated by molecular 
dynamics for 20 ps, with positional restraints on the protein atoms. The relaxed structures obtained 
in this way are the start configurations for our main molecular dynamics runs. 
 
5.2.2. Simulation Protocols 
 
Our molecular dynamics simulations are performed by using the GROMACS 2018.2 software 
package.201 Protein−protein and protein−water interactions are modeled with the CHARMM 36m 
force field202 and the TIP3P152 water model, a combination that is known to perform well in 
simulations of the amyloid assembly.203 We use the LINCS algorithm153 to constrain the bond 
length and the SETTLE algorithm154 to maintain the water geometry. As periodic boundary 
conditions are selected, we use the particle mesh Ewald algorithm181 to calculate the electrostatic 
interaction with a cut-off distance of 1.2 nm, the default value in GROMACS for electrostatic and 
van der Waals interactions. 
The molecular dynamics simulations are performed in an isothermal-isobaric (NPT) ensemble, 
with temperature set to 310 K using a v-rescale thermostat180 and pressure set to 1 bar using a 





using the leapfrog algorithm as implemented in GROMACS.201 Each system is followed over three 
independent trajectories of either 1 μs (monomers) or 500 ns (hexamers) duration, starting from 
distinct configurations derived from the above generated models by introducing a small random 
movement to the coordinates and randomizing the velocity distribution. Measurements are taken 




Time evolution of structures is followed by calculating the root-mean-square-deviation (rmsd) to 
the start configuration using our in-house code. Similarly, we measured the solvent accessible 
surface area (SASA) and the cavity diameter ⟨dcavity⟩ with our in-house codes. The later quantity is 
approximated by averaging over the center-of-mass distances between the N-terminal helix-I 
segments of adjacent units of both layers. This approximation is justified as each of the two trimer 
layers (see Figure 5.1b) is formed from the helices in the respective chains through a circular head-
to-tail packing, where helix-I remains within the interior cavity. Another measure for the similarity 










The sum runs over the N pairs of (i,j) nonhydrogen atoms i and j belonging to residues θi and θj 
that form a contact in the start configuration, that is, their distance is less than 4.5 Å in the start 





conformation X, while r0ij represents this distance in the native state. β is a smoothing parameter 
taken to be 5 Å−1, and the factor λ accounts for the fluctuation when contact is formed, taken to be 
1.8. 
Correlations between contacts, defined here by the condition that the distance between two 
residues i and j (with |i − j| > 3) is less than 4.5 Å, are quantified by the intermittent time correlation 





Here, h(t), a population variable, is set to one if a pair of residues is in contact at a particular time 
t and zero otherwise. We have also calculated similar TCFs for the helicity, CH(t), where the 
population variable h(t) is now set to one if a residue is in helix at a particular time t and zero 
otherwise. 










where angular brackets mark ensemble averages, Δri and Δrj are the displacement vectors of the i-
th and the j-th Cα atoms of the protein, respectively. C(i,j) can vary by definition between +1 
(complete correlated motion) and −1 (complete anti-correlated motion). Correlated residues move 





The motion of secondary structure elements is quantified by measuring the dipole moments of 
various helices and comparing them with the ones observed in the start configurations. For this 
purpose, we define the dipole moment of a helix, μ, as 





where ri and r0 represent the position vectors of the i-th backbone atom and the center of mass of 
the helix, respectively, while qi is the partial charge of the respective backbone atom. Because the 
three helices differ in their number of residues, we have normalized the magnitude of the dipole 
moment vector by dividing it by the respective number of residues. 
The stability of configurations is also evaluated by calculating the NMR N−H bond order 
parameter. Following Zhang and Brüschweiler,211  we define the order parameter for the i-th 
residue Si2 as 
𝑆!" = tanh^0.8Alexp_−𝑟!@G,NQ ` + 0.8 exp_−𝑟!,N) `o
N
a + 𝑏					(5.5) 
 
where k runs over all the nonhydrogen atoms except those from residues i and i-1. rH and rO denote 
the distance from the nonhydrogen atom k to the amide hydrogen in residue i and carbonyl oxygen 
in residue i − 1, respectively. The parameter value b = −0.1 is motivated by the observation that 
one finds usually for rigid protein regions, an order parameter value of around 0.9. Note that we 
have used the corrected version of Si2 211 according to which the distances riO−1,k and rHi,k in eq 5 











Recent experiments have established that the 104-residue serum amyloid A SAA1−104 assembles as 
a hexamer in its biologically active state and forms a complex with HDL in blood serum. 
Dissociation of the hexamer, which is not amyloidogenic,212  is assisted by binding to GAGs, such 
as heparin/HS. The so-formed SAA monomers are in the second step cleaved by enzymes into 
shorter fragments with the 76residue fragment SAA1−76, which is the most commonly found 
species. In principle, one can think of two reasons for the cleavage. First, cleavage may aid 
downregulation of the SAA activity by shifting the equilibrium toward monomers making a 
reassembly toward the biologically active hexamers less likely for SAA1−76 than for the full-sized 
SAA1−104. A second possibility is that the shorter fragments allow for a faster degradation, allowing 
in this way for rapid reduction of the SAA concentration. 
In the present section, we focus on the role of the cleavage for the equilibrium between the hexamer 
and monomer exploring how SAA1−104 and SAA1−76 hexamers differ in their stability and decay 
dynamics. In order to ensure convergence, we have monitored the time evolution of the rmsd of 
the hexamer SAA1−76 and SAA1−104 with respect to their start configurations, taking into account 
all the nonhydrogen atoms in residues 1−76. This choice allows us to compare rmsd values for the 
two systems despite their unequal length. Our results are shown in Figure 5.2 and demonstrate that 
both systems equilibrate after approximately 200 ns. For this reason, we consider only the last 300 
ns of the 500 ns long trajectories for further analysis. Snapshots of the final configurations of each 
run are shown in Supporting Information Figure S5.1 and help to visualize the structural changes 





relation to the SAA1−104 hexamer are indeed markers for differing thermodynamic stability, we 
have performed additional molecular dynamics simulations of the two hexamers at elevated 
temperatures of 325, 350, 375, and 400 K. Set-up and simulation protocol are analog to the ones 
described in Section 2 and trajectories are followed over 350 ns. The corresponding time evolutions 
of rmsd are shown in Figure 5.2c,d. As expected, the rmsd values rise in both systems faster and 
higher with increasing temperature. However, while in the case of SAA1−104, the final rmsd values 
vary within 3−4.5 Å for temperatures up to 375 K and a value of 5 Å is already reached at 325 K 
for SAA1−76. Both this difference in final rmsd values and their growth rate with time indicate a 
lower thermal stability of the SAA1−76 hexamer compared to the SAA1−104 hexamer. 
 
 
Figure 5.2. Time evolutions of rmsd for all three trajectories of (a) SAA1−104 and (b) SAA1−76 
hexamers. The rmsd values are calculated with respect to the start hexamer configuration 
considering all the nonhydrogen atoms in residues 1−76 in each of the six chains. The average 







In order to find the origin of the lower stability of the SAA1−76 hexamer, we have calculated the 
average cavity diameter ⟨dcavity⟩ and the SASA of both hexamers. While the cavity diameter is 
similar (24.5 ± 0.2 Å for SAA1−76 and 24.3 ± 0.7 Å for SAA1−104), individual residues are more 
exposed to the solvent for SAA1−76, leading to the larger SASA values (55.5 (0.3) Å2 compared to 
51.2 (0.4) Å2 for SAA1−104, see Supporting Information Table S5.1). This higher solvent exposure 
suggests that the lower SAA1−76 hexamer stability, leading to the higher rmsd values seen in Figure 
5.2, is caused by increased flexibility of individual residues in the six chains. 
 
This higher flexibility of residues in the SAA1−76 hexamer results from the missing favorable 
interchain hydrogen bonds, salt-bridges, and hydrophobic interactions that stabilize the SAA1−104 
crystal structure.7 This can be seen in Figure 5.3, where we show the (a) fraction of all native 
contacts and the (b) same quantity restricted to intrachain native contacts. Corresponding to the 
increase in rmsd, the fraction of native contacts decreases with time for both hexamers, with the 
loss of native contacts more pronounced for the SAA1−76 hexamer than for the SAA1−104 hexamer. 
As in both cases, only contacts formed by the first 76 residues are considered; it follows that the 








Figure 5.3. Time evolutions of the fraction of native contacts (Q) are shown in the left column, 
considering either (a) all native contacts, (b) only intrachain native contacts, or (c) only interchain 
native contacts. Data are from the first trajectory of either the SAA1−76 or the SAA1−104 hexamer 
simulation. The right column presents plots of the intermittent contact TCF, Ccontact(t), considering 
either (d) all contacts, (e) only intrachain contacts, or (f) only interchain contacts, formed in 
SAA1−76 and SAA1−104 hexamers. Data are from all three trajectories for each system, but only the 
last 300 ns is considered for calculating Ccontact(t). For comparison, we show also for the full-sized 
SAA1−104 hexamer the corresponding values for the case when only contacts between residues 1 
and 76 are taken into account. 
 
Surprisingly, the fraction of interchain contacts, as shown in Figure 5.3c, is higher for SAA1−76. 
This on first look unexpected result is likely caused by the higher flexibility of the SAA1−76 chains, 
which allow them to form interchain contacts more easily. However, these interchain contacts are 
transient and do not contribute to the stability of the hexamer. This can be seen from Figure 5.3d−f, 
where we show TCFs of the contacts, taking into account either all contacts or considering only 
either interchain or intrachain contacts. Irrespective of the type of contacts, TCFs for the SAA1−76 





quickly approaches a plateau. This is also the case when for the later only residues 1−76 are 
considered. The decay time is especially short for the interchain contacts in the SAA1−76 hexamer, 
demonstrating the short life times and the transient nature of these contacts. Hence, the additional 
interchain contacts can only partially compensate for the loss of stability resulting from the reduced 
number of intrachain contacts as their lifetimes are short, and overall, the total fraction of native 
contacts is lower for SAA1−76 hexamers than for SAA1−104 hexamers. Hence, the intrachain contacts 
rather than the interchain contacts determine the overall stability of the SAA hexamers. 
The above discussion implies that when part of the hexamer, the intrinsic stability of the folded 
SAA1−104 chains is higher than for the SAA1−76 chains. This is supported by Figure 5.4a, where 
we show the residue-wise NMR order parameter (S2 ) of the first 76 residues of both proteins, 
averaged over all six chains in a hexamer and all three trajectories. The lower the value of S2 , the 
higher will be the flexibility of the respective N−H bond and hence the corresponding residue and 
vice versa. Comparing the two proteins, we find a signal for increased flexibility of SAA1−76 
chains in two regions: one made of residues 30−43, and the other of residues 63−76. These residues 
have a higher probability to interact with the solvent, starting in this way the dissociation process 
of the hexamer. Figure 5.4b confirms indeed that the SASA of these residues, belonging to either 
helix-II or helix-III, is higher for SAA1−76 than for the full-sized SAA1−104, where the C-







Figure 5.4. Residue-wise (a) backbone N−H order parameter (S2) and (b) SASA for the SAA1−76 
and SAA1−104 hexamers as calculated over the last 300 ns of all three trajectories. Data are shown 
only for the first 76 residues. 
5.3.2. Monomer 
 
In the abovementioned section, we have demonstrated that hexamers formed by SAA1−104 have 
a higher stability than those formed from the fragment SAA1−76. Hence, it is unlikely that 
SAA1−76 and similar fragments, once generated by enzymatic cleavage from the full sized protein, 
will reassemble into a hexamer and if formed by chance, such a hexamer would decay quickly. 
However, it is not clear whether the sole purpose of the cleavage is inhibiting reassembly into the 
biologically active hexamer. Another reason for the cleavage could be to decrease the SAA 
concentration by easing degradation of the protein. We have already shown in the previous section 
that within the hexamer, the SAA1−76 chains have lower internal stability than full-length 





structural changes of fragments that could encourage proteolysis. However, the higher flexibility 
would also increase the risk of aggregation as it could lead to release of the first eleven residues 
from helix-I. These N-terminal residues are considered to be crucial for amyloid formation. Hence, 
in order to probe the effect of the cleavage on stability and potential amyloid-forming tendencies 
of SAA monomers, we have also studied the isolated monomers of the full-length SAA1−104 and 
the SAA1−76 fragment in another set of molecular dynamic simulations. 
Similar to the hexamer, we first establish what part of the simulated trajectories can be used for 
analysis. For this purpose, we monitor for the two monomers the time evolution of rmsd with 
respect to their start configurations considering again only the nonhydrogen atoms in the first 76 
residues. As for the hexamers, we show the last snapshots of each runs in Supporting Information, 
Figure SF2, to highlight the structural changes of the monomers. Our results, as shown in 
Supporting Information, Figure S5.3, are similar to the hexamers in which the changes of rmsd are 
smaller for SAA1−104 monomers (around 2 Å) than for the SAA1−76 monomers (around 6−12 
Å), which again have more pronounced fluctuations. However, as a plateau is approached for both 
molecules and the simulations converge in about 500 ns, 500 ns of the 1 μs-long trajectories remain 
for our analysis. 
 
The stability differences between SAA1−76 and SAA1−104 monomers, seen in the time evolution 
of rmsd, are further investigated by comparing the average number of native contacts (⟨Nnat⟩), 
residue−residue contacts (⟨Nc⟩), and helicity (⟨h⟩). In Table 5.1, we list the differences of these 
values to the ones measured in the respective start configurations. For the full-sized protein, we 
have also calculated these values restricted to the first 76 residues and have added the values in 





of ⟨Nnat⟩ for SAA1−76 monomers (in relation to full-length monomers) confirm the larger 
deviations, and in turn, lower stability of the truncated fragment. This difference is also seen when 
only the first 76 residues of the full-sized protein are considered. Similarly, the loss of helicity ⟨h⟩ 
is larger in the fragment than in the full-sized protein. On the other hand, the total number of 
contacts ⟨Nc⟩ is approximately the same in the truncated fragment and between residues 1−76 of 
the full-sized protein, indicating that the fragment not only loses helical contacts but the structure 
of the fragment changes and new contacts are formed. 
 
Table 5.1. Difference of Various Quantities with Respect to the Start Configuration, Measured in 
All Three Trajectories of SAA1−76 a and SAA1−104 Chains in the Hexamer and in Isolated 
Monomers 
 
aDifferences calculated for the solvent accessible surface area ⟨ΔSASA⟩ per residue (in Å2), 
number of native contacts (⟨ΔNnat⟩), number of nonnative contacts (⟨ΔNnon⟩), and helicity (⟨Δh⟩). 
For comparison, we also present data for SAA1−104 chains considering only the first 76 residues. 
Averages are taken over the three trajectories with the standard deviations listed in parenthesis. 
 
For the full-sized protein, the loss of native contacts is mainly in the C-terminal region, with only 
few (about 10%) of native contacts within residues 1−76 lost in the first 1 μs. This demonstrates 
the protective role of the C-terminal segment of residues 77−104 and indicates that after cleavage, 





chain−side-chain contact maps, as shown in Figure 5.5, which shows that absence of the C-
terminal tail leads SAA1−76 to lose the contacts between residues 70−76 and 60− 69, that is, the 
cleavage increases the flexibility of helix-III. In turn, contacts between residues 32−38 and 65−67, 
located on helix-II and helix-III, are also dissolved. A similar loss of interhelix contacts is seen 
between helix-I (residues 26−28) and helix-II (residues 32−34). This reduction in the number of 
contacts increases the residue-wise SASA in the fragment, see also Supporting Information Figure 
S5.4. Similar to that of the hexamer, most of the residues present in helix-II of the truncated SAA 
monomer become more exposed toward the solvent. The difference in SASA between the fragment 
and the full-sized monomer is the largest for the residues 30−40, belonging to helix-II, and about 
10% larger in the monomer than in the hexamer. This SASA difference results from the weaker 
contacts of helix-II with the adjunct helices I and III in the fragment. This is consistent with the 
fact that, as shown in Supporting Information Figure S5.2, helix-II loses the contacts with both 
helix-I and helix-III that are present in the native structure. However, the SASA values of the 
residues 57, 58, 61, 64, 65, 68, and 69 on helix-III, which in the native structure form contacts with 
helix-II, do not increase after losing the contacts. Instead, the SASA values even decrease, 
indicating that these hydrophobic residues have formed alternative contacts, leading to a structural 















Figure 5.5. Side-chain−side-chain contact map of (a) SAA1−76 and (b) SAA1−104 monomers as 
calculated over the last 500 ns of all three trajectories of each system. Data are shown only for the 
first 76 residues. Residue pairs whose average contact distance is more than 10 Å are excluded. 
 
 
Hence, cleavage of the C-terminal tail destabilizes the native structure of SAA monomers through 
reducing interhelix contacts and increased solvent exposure. As soon as (after release from the 
hexamer) the full-length SAA monomers are cleaved and lose the C-terminal tail (including helix-
IV), their native structure decays, and the chains are unlikely to re-associate into a hexamer. On 
the other hand, unfolding of the full-length monomer structure (SAA1−104) happens, if at all, only 
on much longer time scales. These longer lifetimes allow the full-length protein, unlike the 
fragment, to reassemble into a hexamer.  
However, the reduced stability of the fragment SAA1−76 affects also the N-terminal eleven 





depends on the length of the cleaved fragment. This can be seen in Figure 5.6, where we show for 
SAA fragments of various lengths the residue-wise NMR order parameter (S2 ) for the backbone 
N−H bond vectors (eq 5). The flexibility of the first eleven N-terminal residues increases 
drastically with subsequent cleavage of the helices, facilitating more misfolding into an 
aggregation prone configuration. A special role here seems to fall to the segment SAA1−76, which 
is in between the two extreme cases of the N-terminal segment fully cached in helix-I (the full-
sized protein made of all four helices) or of the N-terminal segment being highly flexible and 
stabilized only by the environment of helix-I (SAA1−27) and helix-II (SAA1−47). This 
intermediate position of the SAA1−76 fragment, therefore, indicates that helix-III takes a special 
role in the misfolding and aggregation of SAA. 
 
Figure 5.6. Residue-wise backbone N−H order parameter (S2) for the first eleven residues of 
different SAA protein monomer fragments, (1− 104), (1−76), (1−47), and (1−27) as calculated 
over the last 500 ns of all three trajectory of each system. For the fragment SAA1−76, we distinguish 
further between helix-broken and helix-weakened structures (see text). Residue-wise backbone 
N−H order parameter (S2) for the first eleven residues corresponding to these two structures of 






In order to understand this special role of helix-III, we have calculated for each helix the 
corresponding dipole moment. The time evolutions of the per residue dipole moment (μ) for all 
three helices are displayed in Figure 5.7a−c, where we depict for this quantity, the magnitude of 
the difference between the actual value and the one measured in the start configuration. While the 
dipole moments of helix-I and helix-II change little with time, that is, when not affected by the 
cleavage of the C-terminal residues, there is a clear signal for helix-III. The change observed here 
in the dipole moment could indicate either breakage of helix-III into two shorter segments 
connected by a kink (named by us a helix-broken configuration) or a shortening of helix-III with 
the released residues taken random orientations (called by us a helix-weakened configuration). 
Visual inspection shows that both possibilities happen: the helix-broken case in run 2 and the helix-
weakened one in run 1 and run 3. The relative orientation of helix-III with respect to the other two 
helices changes in both motifs, as seen from the relative orientation between pairs of helices in 
Figure 5.7d−f and the center-of mass distances between these pairs in Figure 5.7g−i. This is 







Figure 5.7. (a−c) Time evolution of the difference in dipole moments (μ) of a helix at a given time 
minus the corresponding value in the start configuration. Shown in the figure are the magnitudes 
of this difference divided by the number of residues for helix-I, helix-II, and helix-III in the 
SAA1−76 fragment. The color code is as follows: helix-I is shown in black, helix-II in red, and 
helix-III in green. In (d−f) we show the corresponding time evolution of the scalar product of 
dipole moment vectors and in (g−i) center of mass distances between pairs of helices. The color 
coding is as follows: values for helix pair (I,II) are displayed in black, for helix pair (II,III) in red, 
and for helix pair (I,III) in green. The results for run-1 is shown in the first row, for run-2 in the 
middle row, and for run-3 in the last row. 
 
In order to go beyond visual inspection, we introduce the following definition for the two motifs. 
In helix-weakened configurations, helix-III is still preserved for residues 50−62, but at most three 
residues are still helical in the C-terminus of helix III (residues 63−69). On the other hand, a kink 
is formed within residues 50−62 in case of helix-broken configuration (i.e., the helicity of this 
segment is less than 13) and the C-terminus of helix-III is preserved (at least five residues are 
helical in the segment 63−69). In both cases, the orientation of helix-III changes toward helix-I 
with the Cα residue distance between residue 1 and 69 (dCα ) less than 20 Å in case of helix-broken 






Our above results show that upon cleavage of the C-terminal residues 77−104, the position of 
helix-III is no longer restrained by contacts with these residues but can now form contacts with 
helix-I. If helix-III moves toward the C-terminal end of helix I, the lack of helix-stabilizing 
contacts will lead to a shortening of the helix and a disordered segment at the C-terminus becomes 
oriented toward the C-terminus of helix-I. On the other hand, if helix-III moves toward the N-
terminus of helix-I, helix-III breaks up into two shorter pieces connected by a kink around the 
residues 55−58, with the C-terminal end of helix-III now pointing toward the first eleven N-
terminal residues of helix-I. We believe that the contrasting realignment of helix-I and helix III 
allows for the helix-weakened motif release the N-terminal residues 1−11 from helix I (which then 
may refold into a βhairpin as needed for attachment of other chains and starting amyloid formation), 
but the helix-broken motif protects these residues from being released from helix-I. This 
assumption is supported by Figure 5.8, where we show how rapidly the contact number and helicity 
measured for the first eleven N-terminal residues change with time. This speed of change is 
quantified by the intermittent TCF of the two quantities, calculated for the helix-weakened case 
from the last 500 ns of run 1 and 3, and the helix-broken case from the last 500 ns of run 2. For 
comparison, we show values obtained for the full-sized SAA1−104 monomer. While for the helix-
weakened configuration both the helicity and the number of contacts of the N-terminal segment 
decay faster than in the more stable full-sized SAA1−104 monomer, there is no qualitative 
difference seen between the helix-broken configuration and the full-sized protein. Hence, our 
results suggest a higher chance for the release of the first eleven N-terminal residues from helix-I 
in helix-weakened configurations than in helix-broken configurations, where the segment is 







Figure 5.8. Intermittent TCF for (a) contact Ccontact(t) and (b) helicity CH(t), where contacts and 
helicity are calculated for the first eleven N-terminal residues of helix-I of either helix-broken or 
helix-weakened SAA1−76 conformations. As a reference, data for SAA1−104 monomers are also 
shown. Representative configurations for the (c) helix-broken and (d) helix-weakened SAA1−76 
structures are presented in the right subfigures. The color scheme of the three helices, helix-I to 
III, is same as in Figure 1. 
 
In order to probe in more detail how the relative movement of helix-III in the two motifs affects 
residues in other parts of the molecule, especially, the first eleven N-terminal residues, we show 
in Figure 5.9a−d, respectively, for both motifs the contact map and cross correlation function, 
C(i,j), between the residues. In the helix-weakened structure the C-terminal residues of helix III 
form contacts with the C-terminal residues of helix-I. Formation of these contacts is by a correlated 
motion of the C-terminal of helix-III (residues 58−69) with the C-terminal of helix-I (residues 
19−27), and a consequently anticorrelated motion with N-terminal of helix-I (residues 1−11), 
driving them in opposite directions. This motion is reversed in the helix-broken structure, where 





residues of helix-I (here primarily the first eleven residues). These additional contacts, which do 
not exist in the helix-weakened structure, stabilize helix-I in the helix-broken structure, that is, 
prevent release of the first eleven residues and their misfolding into an amyloid-prone 
configuration. The motif is further stabilized by a reorientation of the hydrophilic residues on 
helix-I, which in the native structure point toward helix-II but in the helix-broken motif face 
outward to the solvent. On the other hand, in the helix-weakened motif, the hydrophilic residues 
stay oriented toward helix-II, but the hydrophobic residues now face toward the solvent, which in 
the native structure is the case for only 30% of the hydrophobic residues on helix-I. Note that 
exposure of such large hydrophobic patches as seen on helix-I in the helix-weakened structure 




Figure 5.9. Side-chain−side-chain contact map of (a) helix-broken and (b) helix-weakened 
SAA1−76 monomer configurations at neutral pH, showing the distance between pairs of residues. 
The corresponding two-dimensional dynamic cross-correlation map C(i,j) of these pairs are shown 
for helix-broken configurations in (c) and for helix-weakened configurations in (d). For the later 
motif, we also show in (e,f) corresponding figures obtained from simulations under acidic 







The already existing stable contacts between the C-terminal end of helix-I and helix-II in the helix-
weakened structure restrict the possibility of formation of new contacts between the C-terminal 
end of helix-III and the C-terminal end of helix-I. This also simultaneously restricts the formation 
of salt-bridges between the opposite charged residues or hydrogen bonds between the side chains. 
On the contrary, repulsion between the similar charged residues on the C-terminal ends of helix-
III and helix-I will further destabilize the overall structure. The only reasonably stable contacts 
that we found in helix-weakened structures are Y21−R62, M24−I65, and R25−I65. However, these 
contacts are neither sufficient to compensate the charge− charge repulsion, and the helix-weakened 
structure is flexible, with frequent transitions toward the original arrangement of helix-I and helix-
III. The net-effect is a loss of the forces that stabilize helix-I in the native structure of the full-sized 
SAA1−104 monomer but are missing in the shorter segments. The resulting higher entropy of 
helix-I leads to its de-stabilization, especially, at the N-terminus as the C-terminus is still supported 
by contacts with helix-III. As a consequence, there is an increased chance for the first eleven 
residues to be released from helix-I and to misfold into strand-like configuration (see inset of 
Figure 5.6) that may start the aggregation process. 
 
On the other hand, in the helix-broken structures, strong contacts are formed between residues 
F4−F68, L7−I65, and F11−F69. The phenyl rings of the pair of Phe residues that is, (F4, F68), and 
(F11, F69) orient in such a way that they remain one upon another with an interplanar angle of 
∼0°, resulting in strong π−π stacking interactions of the phenyl rings. The result is a helix−helix 





stabilizes the overall structure but, especially, the N-terminus, keeping the first eleven residues 
cached in helix-I and therefore reducing the probability of their misfolding and subsequent 
aggregation. 
 
Hence, based on our observations, we propose the following mechanism for tuning the SAA 
concentration. After the release of SAA1−104 chains from the hexamer enzymatic cleavage, it 
leads to SAA1−76 monomers that are unstable as they lack the helix− helix linkage interaction 
between helix-III and helix-IV. The C-terminal of helix-III becomes exposed, and helix-III can 
now move relative to helix-I. This process is facilitated by formation of transient contacts between 
residues 20−21 (in helix-I) and 61−62 (in helix-III), which now permit movement of the C-
terminus of helix-III toward either the C-terminus or N-terminus of helix-I, that is, enabling 
transitions between the two resulting structures, coined by us helix-weakened and helix-broken 
structures. With only three runs, we do not have sufficient statistics to quantify the relative 
frequency of the two motifs, but our simulations indicate that after cleavage of the full-length 
protein, most SAA1−76 monomers evolve into a helix-weakened configuration. 
 
We conjecture that in helix-weakened configurations the large exposed hydrophobic patches on 
helix-I will activate further proteolytic degradation, likely by protease cathepsin D41 after binding 
with the heat shock protein Hsp70213-215 recruited in response to the primary disease. The net-effect 
would be a reduction in the SAA concentration. However, the larger flexibility of the N-terminal 
segment of the first eleven residues also increases the risk that these residues unfold from helix-I 
and take strand-like configurations which could nucleate amyloid formation. Under neutral pH, 





residues 1R and 9E. This salt bridge (defined by us by the condition that the center-of-mass 
distance between the ammonium or carboxylate groups of residues 1R and E9 is below 4 Å) is 
formed in about 70% of the full-length SAA1−104 monomers but only in about 25% of the helix-
weakened SAA1−76 configurations. On the other hand, in helix-broken configurations, this salt 
bridge is found with similar frequency as in the full-length protein, and the N-terminal segment is 
stabilized additionally by interactions with the C-terminal of helix-III. Hence, the helix-broken 
configurations are less aggregation prone than helix-weakened configurations. We hypothesize 
that this difference is minor under neutral conditions making helix-weakened configurations more 
desirable than helix-broken configurations, which do not have large hydrophobic patches exposed 
to the solvent and therefore are more difficult to degrade. 
 
The situation may be different under acidic conditions such as seen in conjunction with cancer or 
inflammatory diseases,216, 217 where this salt bridge between residues 1R and 9E can no longer be 
formed. In preliminary simulations, where we approximate acidic conditions by fixing the 
protonation of charged residues to states given by the known pKa value of the free residue and the 
selected pH-value, the salt bridge is found at pH = 5 in only about 40% for helix-broken and about 
15% for helix-weakened configurations and at pH = 4 it is less than 5% of the SAA1−76 
configurations. The disappearance of the salt bridge will likely increase the chance for aggregation 
and amyloid formation with the risk mitigated in helix-broken configurations by the additional 
contacts between the N-terminal segment and the C-terminus of helix-III. Interestingly, we also 
observe in the same set of simulations a shift from helix-weakened to helix-broken configurations, 
when going to acidic conditions, see Figure 5.9e,f. This transition between the two forms, therefore, 





that stabilizes this segment through additional contacts with helix-III. Hence, this pH-driven 
transition between helix-weakened and helix-broken configurations appears to be a mechanism to 
counteract the increased chance for aggregation and amyloid formation, otherwise often seen under 
acidic conditions.216, 217 Unfortunately, it would not make sense to quantify the free energy 
differences between the two forms as function of pH, as our approximate treatment of pH limits 
the reliability of our measured data. For a more quantitative treatment, one would need to utilize 





Various diseases cause overexpression of the SAA protein leading in some, but not all, cases to 
amyloidosis as a secondary disease. The response to overexpression involves dissociation of the 
SAA hexamer and subsequent enzymatic cleavage of the full-length SAA1−104 chains into shorter 
fragments most commonly the 76-residue fragment SAA1−76. Analyzing extensive molecular 
dynamics simulations, we propose a mechanism to downregulate the SAA activity and 
concentration that relies on this cleavage and is sketched in Figure 5.10. As SAA in its functional 
form assembles into hexamers, we have first tested the hypothesis that the cleavage shifts the 
equilibrium for SAA1−76 fragments from the biologically active hexamers to potentially 
amyloidogenic monomers. Our molecular dynamics simulations confirm that hexamers built from 
full-length SAA1−104 chains are indeed more stable than such formed from SAA1−76 fragments. We 
explain this lower stability with the larger exposure of helix-II and helix-III in the SAA1−76 hexamer 
chains. This lower stability reduces the chance for the SAA1−76 fragments to reassemble into a 





Our hexamer simulations also suggested a higher internal stability of the full-length SAA1−104 
chains compared with the SAA1−76 fragments. As the reduced stability of the fragment likely 
triggers further degradation, reducing SAA concentration, we have added molecular dynamics 
simulations of isolated monomers to probe also the lower stability of the SAA1−76 fragments. As 
the first eleven residues are crucial for amyloid formation,23 we were especially interested in the 
question of how the cleavage affects the stability of this N-terminal segment which is part of helix-
I (residues 1−27) in the native structure and protected by the C-terminal tail (including helix-IV). 
On the other hand, in SAA fragments too short to contain helix-III (residues 50−69), helix-I is less 
protected, and only a transient salt bridge between residues 1R and 9E stabilizes the helical 
configuration of the N-terminal segment.200 Especially under acidic conditions, where this salt 
bridge cannot be formed, the N-terminal residues may unfold to form strand-like segments26, 200 







Figure 5.10. Sketch of the proposed mechanism that balances the desire for the downregulating 
SAA activity and concentration with the need to avoid harmful aggregation. 
 
SAA1−76 fragments are on the cusp between structures, where the N-terminal residues are firmly 
integrated in helix-I (as in the full-length protein) and such where they are flexible enough to be 
released easily from helix-I, see Figure 5.6. This is because interactions with helix-III may either 
stabilize or de-stabilize helix-I. Because the fragment SAA1−76 lacks the helix−helix linkage 
interactions between helix-III and helix-IV, seen in the full-length protein, the C-terminus of helix-
III is able to move toward either the C-terminus of helix-I or toward the N-terminus of helix-I. The 
first and more common case leads to helix-weakened structures characterized by a weakened helix-
III causing large exposed hydrophobic patches on helix-I that will trigger further degradation by 
the proteosome, therefore, reducing the SAA concentration and downregulating the SAA activity. 
However, this motif is also characterized by a reduced stability of helix-I which raises the 





point for subsequent amyloid formation. This is especially the case under acidic conditions, where 
the transient salt bridge 1R−9E cannot be formed that stabilizes the helical conformation of the N-
terminal segment under neutral conditions. On the other hand, in the helix-broken structures, newly 
formed contacts between the C-terminus of helix-III and the N-terminus of helix-I stabilize the 
latter helix, reducing the probability that the aggregation-prone first eleven residues are released 
from helix I. Hence, the increased risk for aggregation and amyloid formation associated with 
acidic conditions is mitigated by switching from helix-weakened to helix-broken configurations, a 
process that we have observed in preliminary simulations designed to mimic an acidic environment. 
The possibility for such transitions may be the reason why cleavage of the full-length SAA protein 
leads most often to SAA1−76 fragments, which by switching between helix-weakened and helix-
broken configurations can optimize the chance for degradation while minimizing the risk of 
aggregation and amyloid formation. In most patients where colon cancer, inflammatory bowel 
disease, or rheumatoid arthritis leads to overexpression of SAA, the described mechanism enables 
downregulation of the activity and concentration of SAA. We speculate that SAA amyloidosis 




The simulations in this work were done using the SCHOONER cluster of the University of 
Oklahoma and XSEDE resources allocated under grant MCB160005 (National Science 







Chapter 6. Stability Study of A Recently Found Human SAA Fibril Structure 
 
 
The material in chapter 6 is work	 that	was	 unpublished	 at	 the	 time	 this	 dissertation	was	
written,	only	preliminary	data	are	included	in	this	chapter.	A	manuscript	is	in	preparation. 




Most of my doctoral research  has focused on identifying the factors that accelerate SAA fibril 
formation, such as enzyme cleavage, low pH condition,  presenting of glycosaminoglycans 
(GAGs). Our previous results showed that enzyme cleavage can shift the equilibrium to monomer 
state. The cleavage always happens in the C-terminal region of SAA and causes significantly 
increasing the flexibility of monomer. The most common fragment of SAA cleavage product is 
SAA 1-76 (contains only the first 76 residues). The fragments can downregulate and protect from 
aggregation by switching the conformation between two identified motifs. Many previous studies 
have revealed that amyloid fibrils are more stable under acidic condition, especially for SAA fibril, 
the early stage of fibril formation happens in lysosomes, the pH condition in lysosome is acidic 
(pH = ~ 4.3), SAA is endocytosed. Then its C-terminus is truncated, N-terminus is misfolded by 
the lysosome/cell, intracellular oligomers appear, and disrupt the lysosome and cell membrane to 
get into the extracellular environment and assemble into fibril structure. 221 This proposed SAA 
fibril formation mechanism indicated that low pH is critical for early-stage fibril formation. Our 





conditions can shift the equilibrium to a fibril formation favorable state. 110, 200 Although key 
interactions stabilizing the amyloidogenic region in native structure have been identified and a 
potential mechanism for SAA cleavage, downregulation and aggregation has been proposed, many 
questions still remain unclear, such as, what interactions are critical in SAA fibril formation, what 
are the driving forces to stabilize SAA fibril.  
 
The kinetics of  fibril formation  is difficult to probe by both experimental or computational studies. 
Computationally more accessible are thermodynamic stability measurements of fibrils. Such a 
stability analysis requires a structural model of the SAA fibrils, which only recently was resolved  
for human and mouse SAA by  electron cryo-microscopy.30 Because of experimental difficulties 
is the human SAA fibril model only available for the fragment SAA2-69, and here only residues 2-
55 have been resolved while residues 56-69 are disordered. However, as SAA1-76  (and not SAA1-
55) is the   most commonly found fragment in human SAA fibrils, it appears to be likely that the 
disordered region, likely extending to residue 76,   plays also a role in fibril formation. 30 
The ordered part of the human SAA fibril adopts a right-hand twist, with each chain forming seven 
β-sheets, β1-β7. The N-terminal region is made of about 20 residues and takes a similar structure 
in both human and mouse SAA fibrils. It is stabilized by hydrophobic interaction involving   six  
hydrophobic residues (F3, F5, F10, M16, Y17, and A19). The C-terminal region of human SAA 
fibril is stabilized by the ionic interactions among the charged residues (D23, R25, E26, K34, D43, 
and R47) buried inside a C-terminal cavity. Two proto-fibrils are packed together in human SAA 
fibrils,  with the packing interface stabilized by ionic, hydrophobic, and polar cross-stack 
interactions.  The interface is a so-called “steric zipper”,  formed by the packing of β3-strands  





N-terminus of chains in one layer of a protofibril with residue D33 of a chain of the same layer in 
the opposite proto-fibril is also stabilizing the packing interface. 30  Compared with the mouse 
SAA fibril is the human SAA fibril packing  much tighter, making us wonder whether  packing 
interactions between two chains may lead to a stable nucleus, i.e., whether fibril formation starts 
with nucleation and elongation of single protofibrils, or whether both protofibrils grow out of 
dimer kept together by packing interactions. Hence, the first question that we pose is that for the 
smallest stable fibril fragment, i.e., the nucleus which starts fibril growth, and whether  this 
fragment is stabilized by stacking or packing. As it is known that acid conditions further SAA 
fibril formation, we ask as a second question how acidic conditions affect the fibril stability. 
Finally, in our third line of research we study the role of  the first eleven residues (amyloidogenic 
region) and residues 56-76 ( disordered region ) for fibril stability. 
 From our molecular dynamics simulations we conclude  that the critical size for fibril stability is  
a two-fold two-layer tetramer. We conjecture that stacking within the same fold precedes packing 
between two folds. Acidic conditions are most important at early stages of fibril formation. By 
altering the salt-bridge network for the C-terminal cavity, they encourage the stacking of chains. 
Our results further suggests that SAA fibril formation is initially dominated by a kinetically 
favorable process where  N-terminal regions of different chains interact with each other and form  
anchors which allow the  chains to stack together. On the other hand, we do not find indications 
that the disordered C-terminal tail alters the stability of the SAA fibril geometry. This observation 
is consisted with C-terminal region (residues 65-76) turned into disorder state to release N-terminal 







6.2. Materials and Methods 
 
Models used in our simulation are generated from the cryo-EM structure as deposited in the Protein 
Data Bank under identifier (PDB ID: 6MST). This model is for the fragment SAA(2-55) i.e., 
without the first residue which we also did not consider in our investigation. The model is a two-
fold six-layer system, from which we successively deleted chains in the bottom and top end layer 
to obtain a sequence of models with two-fold three-layers (F2L3),  two-fold two-layers (F2L2), 
and two-fold one-layer(F2L1).  By deleting one of the folds,  corresponding single-fold models 
are generated, i.e.,  one-fold three-layers (F1L3),  one-fold two-layers (F1L2) , and one-fold one-
layer (F1L1) systems. In order to test the role of the first eleven N-terminal residues we generated  
also a series of truncated models (F1L1-,F1L2-,F1L3-,F2L1- and F2L2-) where these residues 
where deleted from the chains. In another series of models (F1L1A, F1L2A, F1L3A, F2L1A, 
F2L2A, F2L3A) we accounted for the effect of acid conditions in an approximated way  by altering 
the protonation states of residues E9, E26, H37 to the one expected at pH=4 while it corresponds 
in the parent models to pH=7. Each of the  single-fold models  is placed in a cubic box of edge 
size  ~ 9.6 nm and filled with ~ 28000 water molecules, while for two-fold models the box has  an 
edge size of ~ 10.4 nm and is filled with ~ 37000 water molecules.  Since  most fibrils taken from  
patients are made  from  the larger SAA(1-76) fragments, we have  in addition  generated one 
model where the residues 56-76 were added. These residues  could not be resolved in the cryo-EM 
structure indicating that that this segment is unstructured. We generated this specific model only 
after we had determined the two-fold two-layer systems as the smallest stable system. Hence, our 
extended model F2L2+ is also a two-fold two-layer  system, with the additional residues 56-76  





~ 17.5 nm that is filled with ~ 74000 water molecules. All  considered models are listed in Table 
6.1. 
 
Table 6.1. List of considered models. 





1 7 No No One One 
2 7 No No One Two 
3 7 No No Two One 
4 7 No No Two Two 
5 7 No No One Three 
6 7 No No Two Three 
7 4 No No One One 
8 4 No No One Two 
9 4 No No Two One 
10 4 No No Two Two 
11 4 No No One Three 
12 4 No No Two Three 
13 7 Yes No One One 
14 7 Yes No One Two 
15 7 Yes No Two One 
16 7 Yes No Two Two 
17 7 Yes No One Three 







Our simulations rely on the GROMACS 2018.2 software package. 201 We use the CHARMM36m 
force field  to describe interactions between atoms, and chose   TIP3P for modeling  water. 152, 202 
The  SETTLE and LINCS algorithms are used for water geometry and bond length constraint. 153, 
154 Particle mesh Ewald algorithm (cut off 1.2 nm) is applied to calculate electrostatic interactions 
for periodic boundary conditions. The same cutoff is used in calculations of van der Waals 
interactions. Molecular dynamics simulations are done in an  isothermal-isobaric (NPT) ensemble, 
181  with the temperature set to 310 K by a v-rescale thermostat and pressure to 1 Bar by a 
Parrinello−Rahman barostat. 180, 204 Three independent trajectories of 100ns length are generated 
for each system.  Each of the three trajectories starts with an initial configurations derived  from 
the  above generated models by  small random variations of coordinates and the velocity 
distribution. Data are collected and stored every 50 ps for later analysis. Only the last 70 ns of the 
trajectories are used for our stability analysis which relies on GROMACS built-in tools and in-
house code for measuring quantities such as RMSD, RMSF, Contact map, etc. 201 
 
6.3. Results and Discussions 
 
6.3.1. Critical size of SAA fibril and potential amyloid formation mechanism 
 
In order to test the stability of the recently resolved SAA fibril structure, we start by determining 
the critical size of the fibril, that is the size above which the fibril is stable over extended periods 
of time while the fibril will be decaying on the time scale of our simulation below this size. We 
show in Figure 6.1 root-mean-square deviations of backbone atoms to the start configuration, and 
root-mean-square fluctuations of the residues, with the values derived by averaging over all chains, 





layer F1L1, i.e., the SAA2-55 monomer, and the two-fold one-layer model F2L1 are unstable, which 
is consistent with visual inspection of the final configurations, see for instance the representative 
structures in fig 6.3. b and e. Hence, our data exclude not only SAA2-55 monomers as possible 
nucleus for fibril formation, but also dimers made of two chains packed together. On the other 
hand, the stability of the models increases while the number of layers increase. Note especially 
that the one-fold two-layer model F1L2, i.e., a dimer made of two chains stacked on each other, 
has higher stability than the two-fold one-layer model F2L1, i.e., the dimer where the two chains 
are in the same plane stabilized by packing interactions. This can be seen from  both the variation 
in RMSD in fig 6.2 and visual inspection, see the  representative structure in fig 6.3. f. Hence, 
while this dimer  is still not stable enough to serve as nucleus for fibril growth, it  may be a 
metastable state on the way to forming the two-fold two layers system F2L2, the smallest assembly 
seen in our simulation that is stable enough to serve as a nucleus for fibril elongation.  
 
 
Figure 6.1. Under pH = 7 condition. a). Average RMSD per chain (overall lowest value among 
three trails are chosen to plot) for different systems, red, F1L1 system, blue, F1L2 system, black, 
F2L1 system, yellow, F2L2 system, orange, F1L3 system, pink, F2L3 system. b). Average RMSF 






Hence, comparing the stability of the various studied  models suggest that at neutral pH the 
formation of the critical nucleus  starts with two  monomers forming mainchain hydrogen bonds 
and stacking  into a metastable dimer, with each chain assuming a fibril-like configurations. 
Packing of two such dimers with their N-terminal region leads to a tetramer where the chain 
configurations are sufficiently stabilized by the interactions between the chains, and this two-fold 
two-layers tetramer then serves as a nucleus for further fibril growth, see fig 6.3. c.  
 
 
Figure 6.2. Average RMSD per chain for three trails of pH = 7 systems,  a). F1L2 system. b). 
F2L2 system. Red, blue and black stand for trial 1 to 3.  
 
The critical size determined by our simulation is also consist with previous measurements of  the 
Gibbs free energy needed for dissociation of two protofibrils. Using PDBePISA it was found that 
a protofibril has to have at least two layers in order for this dissociation energy to be positive. 30 
With growing number of  layers decrease the RMSD and RMSF values of the various systems 
studied in our simulations. The  differences between the observed stabilities are small, and   
systems larger than the critical size preserve their fibril structure on the time scale of our 
simulations, i.e., can be considered to be stable., see also the representative final configurations in 






Figure 6.3. At pH 7, a). Initial structure (F2L2 system). Representative structure of b). F2L1, c). 
F2L2, d). F2L3, e). F1L1, f). F1L2, g). F1L3 systems. Red and Blue balls are N-terminus and C-
terminus. Yellow, cyan and gray stand for β-strand, turn and coil. 
 
6.3.2. Acidic conditions enhance early stage aggregation 
 
The situation is different under acidic conditions at pH 4, which we have simulated in a simplistic 
way by protonating the sidechains of Glutamic acid and Histidine.  While the general patterns 
resemble that seen in the simulations done under neutral pH conditions,  the RMSF  for the  one-
fold two layers system F1L2A  (fig 6.4a) is smaller than the one for the corresponding system at 
pH 7, namely F1L2.  Differences are especially seen for   residues 12 – 37 and for the C-terminal 
cavity region former by residues 45 – 55. The lower root-mean-square fluctuations imply a higher 
stability of this assembly than seen under neutral condition. These differences in RMSF and 
stability are not seen when comparing  the two-fold two-layer  F2L2A tetramer with the 





raise the  stability of fully-formed fibrils, see fig 6.4 c-d, we conjecture that they  increase the 
probability for  fibril formation by making it easier to form a nucleus.  Under acidic conditions 
leads the stacking of two chains  to a  dimer that is more stable than  it is at pH=7. The resulting 
longer lifetime makes it more likely for such a dimer  to find a partner  and assemble to the F2L2 
tetramer that is the critical nucleus.  
 
 
Figure 6.4. Average RMSF value comparison for same system size under different pH conditions, 
red, pH = 7, black, pH = 4. a). F1L2 systems. b). F2L2 systems. c). F1L3 systems. d). F2L3 systems  
 
 
What causes the additional stabilization of the F1L2 dimer at acid conditions? From fig 6.5 a)-b) 





contribute to stability, while under acidic conditions additional contacts are found inside the  C-
terminal cavity, such as between residue E26 and group K46-R47-G48,  and between group R25-
E26, K34 and D43. Note especially the role of residue E26, which becomes protonated at pH=4, 
allowing it to form multiple sidechain hydrogen bonds and salt-bridges in the C-terminal cavity 
(residues 23 - 51) which further stabilize the meta-stable dimer.  With the changing of protonation 
state, instead of salt-bridge interactions between E26 and K34 or E26 and K46 at pH 7 condition, 
E26 forms sidechain interaction with D43 at pH=4 condition. The shift of E26 hydrogen bond 
makes the interaction between R25 and D43 possible at pH 4 condition. Furthermore, and both 
D23 and R25, R47 and D43 can form strong sidechain interactions with occupancy of 49.6 % and 
27.2 % respectively under pH 4 condition. At pH 4 condition, interactions between R25 and D43, 
E26 and D43 can connect group D23-R25-E26 and group R47-K46-D43, and along with the 
connection with group Y35-K34-D33-Y29, a stronger salt-bridge/hydrogen bond network forms 
in C-terminal cavity. At pH 7 condition, only and group R47-K46-D43 and group Y35-K34-D33-
Y29 are connected, and E26 is only weakly (7.1 % occupancy) connected to group R47-K46-D43, 
see fig 6.6. for details. Hence, the different  pH conditions  alter the intrachain sidechain hydrogen 












Figure 6.5. Intrachain sidechain contact map, a) – c), one-fold two-layers systems, a), F1L2, pH 
= 7, b). F1L2, pH = 4, c). F1L2-, pH = 7. d) – f), two-fold two layers systems, d), F2L2, pH = 7, 
e). F2L2, pH = 4, f). F2L2-, pH = 7. Color bar stands for distance in nm unit.  
 
This hydrogen bond network shifting observation is also consist with the sidechain contact we 
captured in fig 6.5. b and could explain the low RMSF value in C-terminal cavity under acidic 









Figure 6.6. Intrachain Sidechain salt-bridge/hydrogen bond network at a). pH 4 and b). pH 7. 
Yellow, black and red lines stand for protein chain, residues and side-chain interactions (average 
occupancy per chain larger than 4 % ). N and C stand for terminus.  
 
On the other hand, see fig 6.5 d)-e), for the two-fold two-layer fibril fragment F2L2 exist already 
at pH=7 a multitude of contacts involving both N- and C-terminal region of SAA chains, and the 
overall stability is similar for neutral and acidic conditions. This indicates that unlike for the meta-
stable F1L2 dimer, N-terminal packing can maintain the stability of the fibril by both inter- and 
intra- chain interactions once a critical size is reached. Hence, acidic conditions do not change the 
stability of fibrils but further their formation by stabilizing early-stage on-pathway meta-stable 
states. 
 
6.3.3. Roles of N-terminal amyloidogenic region and C-terminal disordered region 
 
The critical role of the N-terminal residues for maintaining both inter- and intra- molecular 
interactions is comparable with previous experimental studies, which showed that the truncation 
of the first eleven  residues prevents SAA fibril formation. Hence, to understand the role of these 





simulations were done at neutral pH. A RMSD and RMSF values comparison for the two class of 
models is shown in figure 6.7.  
 
Figure 6.7. Under pH = 7 condition without residues 2-11 for each chain. a). Average RMSD per 
chain (overall lowest value among three trails are chosen to plot) for different systems, red, F1L1-
system, blue, F1L2- system, black, F2L1- system, yellow, F2L2- system, orange, F1L3- system, 
pink, F2L3- system. b). Average RMSF value for different systems, the color scheme is the same 
as a). 
 
For one-fold models, F1L1-,F1L2-,F1L3-,  the lack of the N-terminal region leads to a more rigid 
C-terminal region, see fig 6.8. a-b, that  implies a higher stability of these fibril models. These 
results appear to contradict  experimental observations  that SAA  cannot form fibrils when  the 
first eleven  residues  are truncated. However, our results can be explained if one assumes that the 
SAA fibril form by a  process where the N-terminal regions serve as anchors, that ease the stacking 
of the rest of chains by enabling interchain interactions. Once the stacking of two chains is 
completed, they will be   stabilized not only by N-terminal residues but also in addition by C-
terminal residues. Our hypothesis implies that existing fibrils will not  dissolve if the first eleven 
residues are cleaved, but that fragments derived from such fibrils with truncated chains cannot 
nucleate fibril growths and elongation. While going beyond the scope of this work, this could in 





of the one-fold two-layer N-terminal-truncated  F1L2- dimer  simulations,  the region spanned by 
residues 12-21 in a chain folds back into a helix, see fig 6.9a. This refolding is not observed for 
the full-sized F1L2 dimer. Hence, while the more rigid C-terminal region is stabilizing the fibril 
geometry, without the N-terminal, stacking contacts involving residues 12-21 are easily lost, 
leading likely to further degradation of  the SAA fibril. Note that also  the N-terminal truncated 
two-fold models, F2L1- and F2L2-,  are  less stable than the corresponding models F2L1 and F2L2 
built from full-sized chains.  This is despite the fact that the intrachain contacts in the C-terminal 
cavity are  increased for each fold, see figure 6.5. f. Hence, the truncation encourages break-up of 
the two protofibrils which, without additional packing contacts will also further decay, see the 
representative structure in fig 6.9b.  
 
Figure 6.8. Average RMSF value comparison for the same system size under different conditions. 
a). red ( pH = 7, F1L2 system), blue (pH = 7,F1L2- system). b). red ( pH = 7, F1L3 system), blue 
(pH = 7, F1L3- system). c). red ( pH = 7, F2L2 system), blue (pH = 7, F2L2- system). d). red ( pH 










Figure 6.9. Representative structure of a). F1L2- and b). F2L2- systems at pH 7. Color scheme is 
consist with fig 6.3. (Purple stands for helix) 
 
 
The experimentally resolved  SAA fibril structure contains a disordered  C-terminus formed by  
residues 56 - 69. This region  likely extends to residue70-76 in the  most common SAA1-76 fibrils.   
Wondering about the role of this disordered region for stability of SAA fibrils,  we have also 
performed fibril simulations where we have extended the chains in the resolved PDB-structure, 
assuming a disordered, random, conformation for the added residues 56-76.  Our data reveal that 
for two-fold stable systems, F2L2+ and F2L3+,  the stability of the fibril region (residues 2 - 55) 
is similar to that  of the  non-extended systems, see fig 6.10 and 6.8d.  Hence, the disordered region 








Figure 6.10. Average RMSD per chain for three trails of pH = 7, systems with extended residues 





SAA in its native structure is stabilized by  intra-chain interactions, especially the salt-bridge 
interaction between residues 9E and 1R, which maintains the stability of N-terminal 
amyloidogenic region and prevents misfolding and aggregation. Also, in the fibril structure studied 
in this work, both N-terminal packing and a network of ionic interaction and hydrogen bond inside 
the C-terminal cavity are  critical for stabilizing the fibril structure. However, we find the  
disordered C-terminal tail  has very limited effects on fibril stability. We  have identified as the 
critical size of fibrils  a tetramer with  two-folds and  two layers, which we conjecture  is formed 
by first stacking two chains on each other, before two such dimers pack together into a  two-fold 
structure anchored  by their N-terminal regions. The critical role of the N-terminus  explains  the 
experimental observation that without the first eleven residues SAA does not aggregate into fibrils. 
We speculate that amyloid formation  requires these residues to unravel from the N-terminal helix 





from a second chain,  forming a β-anchor that is the starting point of fibril formation. While our 
stability analysis gives already some hints on the underlying dynamics of SAA fibril formation, 





































In this thesis, two proteins, Aβ and SAA, lead to amyloidoses are discussed. Despite having 
different sequence, Aβ and SAA both exhibit highly organized cross β fibril structures. Previous 
experimental studies were fruitful in revealing high resolution fibril structures, however,  the 
understanding of soluble oligomers and intermediates is not as deep as amyloid fibril structure 
despite of these soluble oligomers to contain more toxicity than mature fibrils.  
Due to the soluble and unstable nature of oligomers, it could be challenging for experimental 
approach to capture them, but the knowledge can provide better understanding of the early stage 
of aggregation. In order to achieve this goal, computational approaches are more suitable to be 
applied. Although molecular dynamic (MD) simulation can provide physic-based atomic structural 
information in nanosecond to microsecond time scale, MD is very likely to trapped in local minima, 
leading to inefficient sampling. Replica exchange molecular dynamics (REMD) introduced in 
chapter 2 can enhance the sampling efficiency compared to MD, it works very well for smaller 
system, once the system increase to above ~ 200 residues with explicit solvent, the computational 
cost will dramatically increase if the temperature interval remains same, In chapter 4, an approach 
called multi-exchange replica exchange molecular dynamics (ME-REMD) was implement and it 
can decrease one fourth of the computational cost, ME-REMD could be a potential solution for 
medium size system.  
However, to continue based on the results of this thesis, since we have already studied the N-





region, and further on our study of hexamer and monomer SAA (both fragments and full-sized 
protein) proposed a mechanism of SAA downregulation under natural and acidic pH, the failure 
of the downregulation eventually leads to aggregation and amyloid formation. From fragments to 
full-sized protein, this bottom-up investigation provide the structure information of SAA as non-
fibril structure from pieces to a relative whole picture, together this two studies provided the 
information of early stage of SAA misfolding and aggregation. Our study of SAA fibril stability 
revealed the key interaction to stabilize the structure and also provide the potential 
treatment/prevention for SAA fibril formation, this study provided information about the post fibril 
formation, a gap of knowledge between early stage and post stage amyloid formation needs still 
to be filled.  
To fulfill the gap, we need to employ appropriate computational methods. Based on previous 
experimental results and our simulations, the SAA native structure is a hexamer and three layers 
and two-fold is the critical size to stabilize the fibril. As discussed above, neither REMD and ME-
REMD can sufficiently explore the transition/intermediates landscape in between native structure 
with high helix content and β-rich fibril structure due to their limitation of system size and 
simulation time scale. Targeted molecular dynamics (TMD)  could be one solution which can 
provide some information of transition pathway, however, the output pathway could be biased due 
to the nature of TMD.  
Our lab has developed an unbiased approach that can fast explore the landscape of the possible 
intermediates, this replica-exchange-with-tunneling (RET) approach can possibly answer 
questions, such as, the transition pathway from native to fibril structure, the key components 





In future work a combination of multi-scale simulation and RET will be used to solve the 
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Figure S3.1. (a) The rmsd of six-chain fragment with force field CHARMM27. (b) 







Figure S3.2. (a) The rmsd of six-chain system starting from the ninth model of pdb structure 

























Figure S4.1. Root-mean-square-deviation (RMSD) to the crystal structure for the full-sized SAA 
protein as function of time (A). The initial configuration is shown in (B) and the final one in (C), 
where helix I is marked in red, helix II-IV in cyan, and the C terminal tail in yellow. Data are from 








Figure S4.2. A and B, Secondary structure probability for the box size of 4.8 nm. C and D, 
Secondary structure probability for the box size of 5.4 nm. E and F, Secondary structure probability 
for the box size of 5.6 nm. The frequency of α-helices is drawn in black, that of turns in blue, and 








Figure S4.3. Distribution of potential energies for the 36 replicas distributed in a temperature 





Figure S4.4. Secondary structure probability analysis for molecular dynamics simulation of the 
















Table S5.1. Solvent Accessible Surface Area (SASA) per residue averaged over all chains in the 
SAA1−76 and SAA1−104 hexamers. We show both the values for the individual trajectories and for 
the resulting averages (with standard deviation listed in parenthesis). For comparison we list also 



































Figure S5.1. The snapshots of (a-c) SAA1−104 and (d-f) SAA1−76 hexamers as obtained at the end 
of each of the three trajectories. The trajectories are shown as follows: first column (Run-1), second 
column (Run-2), and third column (Run-3). Color coding of the helices: helix-I (red), helix-II 

























Figure S5.2. The snapshots of (a-c) SAA1−104 and (d-f) SAA1−76 monomers as obtained at the end 
of each of the three trajectories. The trajectories and color coding of the helices are same as that 


























Figure S5.3. Time evolution of the root mean square deviation (RMSD) of isolated (a) SAA1−76 
and (b) SAA1−104 monomers, taking into account all non-hydrogen atoms in the first 76 residues. 
Data are shown for all three trajectories of each system. The RMSD values are calculated with 




























Figure S5.4. (a) Average residue-wise solvent accessible surface area (SASA) of SAA1−76 and 
SAA1−104 monomers as calculated over the last 500 ns of each of the three trajectories of each 
system. Data are shown only for the first 76 residues. In (b) we show for each residue the difference 
∆SASA = SASA(SAA1−76)−SASA(SAA1−104) calculated either for the isolated monomer or 
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